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III. SUMMARY
The yeast vacuolar protein aminopeptidase 1 (Ape1p) is synthesised as a
cytosolic precursor that is transported to the vacuole via the cytoplasm to vacuole
transport (Cvt) pathway. The cytosolic protein is enclosed in a double-membrane
vesicle, which is transported to and fuses with the vacuole releasing a single-membrane
autophagic body into the vacuolar lumen. This is degraded and the precursor sequence
of aminopeptidase 1 is removed. The Cvt pathway involves proteins that are involved
also in macroautophagy. The cytosolic precursor protein and the matured vacuolar
protein form homododecameric complexes. Only the matured homododecameric
complex shows enzymatic activity. We developed a new genetic screen to isolate
mutants in the biogenesis of the vacuolar aminopeptidase 1 based on the enzymatic
activity. New mutants defective in the transport of aminopeptidase 1 to the vacuole have
been isolated. Two of them have been characterised in detail. Those have defects in the
dodecamer formation of the precursor form and accumulate it in pre-vacuolar vesicles.
This suggests interdependence between the dodecamer formation and the formation of
transport competent Cvt vesicles. The tentative identification was based on the
screening of a yeast genomic library and sub-cloning of the particular genes. The effects
of overexpression of some heat shock proteins, which are known to assist protein
translocation processes, protein folding and assembly, indicated the participation of
these factors in early events of the Cvt-pathway.
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1. INTRODUCTION
1.1. Yeast Saccharomyces cerevisiae as a model system to study organelle
biogenesis
Yeast Saccharomyces cerevisiae has several advantages for studying cellular
biology of eukaryotes. The knowledge accumulated in the last two decades
demonstrates that many of the fundamental cell biological processes are highly
conserved among eukaryotic cells. Second, the entire genome of S. cerevisiae has been
characterised genetically and physically. Third, yeast genetics enables the identification
of proteins based on their cellular functions.
Haploid cells of S. cerevisiae exhibit either of two cellular phenotypes, the
mating types a or a . These cells can reproduce vegetatively by a mitotic cell cycle.
However, when cells of opposite mating type are cocultured, they exit the mitotic cell
division cycle and conjugate, producing the yeast diploid (a/a ) zygote. Like the haploid
cells, a/a  cells can reproduce by mitosis, but unlike a or a  cells, a/a  cells can not mate.
Instead, they have the ability to undergo meiosis and sporulation when nutrients are
limiting, thereby regenerating the two haploid cell types (figure 1). This allows random
mutagenesis of the haploid genome and search for mutant cells expressing the desired
phenotype. The genome of a mutant cell can be purified from non-related mutations by
subsequent rounds of mating and meiosis. If the phenotype of the mutant cell is
inherited 2:2 among the four spores, the phenotype is expressed independent of the
segregation of the chromosomes and depends on a single mutation. The mutated genes
are then identified by transforming of the mutant with a wild type yeast chromosomal
DNA library.
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Figure 1: The life cycle of budding yeast cells
  (according to Alberts et al., 1994)
   A haploid nucleus was designed with „n“ and a diploid nucleus with „2n“,
   respectively.
1.2. The vacuole of Saccharomyces cerevisiae
1.2.1. Biogenesis and functions of the vacuole
Vacuoles are the largest compartments of the yeast, occupying up to 60% of the
cell volume. They share many features with lysosomes in animal cells and tonoplasts in
plant cells. All are organelles of low pH, rich in hydrolytic enzymes, surrounded by a
single membrane. During cell growth, portions of the vacuole from the mother cell are
transported into developing buds, indicating that specific cellular mechanisms exist that
ensures partitioning of the organelle between dividing cells. In yeast Saccharomyces
cerevisiae, the vacuole is involved in numerous cellular processes. The various
functions of the vacuole rely on the specific and efficient delivery of its resident
proteins (Harding et al., 1995). Vacuoles function in intracellular digestion of
macromolecules. In response to changing growth conditions of yeast cells, the organelle
undergoes dynamic changes. It serves as a major storage compartment for basic amino
2n
2n
2n
n
n
n
n
proliferation of
diploid cells
meiosis and sporulation
Conjugation
n
n
n
n
Some widely used strains
proliferate as haploid cells
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acids, inorganic phosphate and calcium ions. Yeast mutants with impaired vacuolar
function are sensitive to extremes of pH and osmotic strength, suggesting that the
vacuole is required for pH and osmotic homeostasis. Protein turnover in yeast is
accelerated in response to nitrogen limitation, and the liberation of amino acids from
intracellular proteins requires vacuolar proteases. Vacuolar protease-deficient mutants
exhibit drastically reduced viability upon nitrogen starvation. Diploids lacking vacuolar
proteases fail to sporulate demonstrating the importance of vacuolar proteolysis for the
survival and differentiation of the organism. (Raymond et al., 1992; Teichert et al.,
1989).
1.2.2. Protein transport pathways to the vacuole
Subcellular compartmentalization is critical to eukaryotic cellular physiology.
Accordingly, eukaryotes have evolved multiple mechanisms to deliver proteins to the
various membrane surrounded subcellular compartments found in these cells. Proteins
are known to enter the vacuole by five different mechanisms (figure 2). (a) The majority
of the proteins are targeted to the vacuole via the secretory pathway. For example,
carboxypeptidase Y (CPY) and proteinase A (PrA) are synthesized in the cytosol, enter
the ER by translocation and further transit from the ER to the Golgi complex, where
they are sorted into the vacuolar delivery pathway. These proteins move through the
common compartments of the secretory pathway as inactive precursor proteins, but
upon delivery to the vacuolar compartment, they undergo proteolytic cleavages and
acquire their mature, enzymatically active form. Their propeptides contain vacuolar
sorting information in addition to maintaining the hydrolases in an inactive state before
their arrival in the vacuole (Horazdovsky et al., 1995). (b) Extracellular proteins
destined for degradation enter the vacuole by endocytosis. For example, mating
pheromones and their receptors are internalized and delivered to the vacuole via an
endosomal intermediate (Oda et al, 1996). (c) Cytoplasmic proteins are taken up into
the vacuole by autophagocytosis, presumably to allow recycling of critical metabolites
(Oda et al., 1996, Tsukada and Ohsumi, 1993; Thumm et al., 1994). In order to survive
starvation conditions, nonessential cytosolic proteins and organelles are sequestrated
within autophagosomes, broken down and reused for essential cellular processes.
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Figure 2: Routes for protein delivery into the yeast vacuole
  (modified according to Scott and Klionsky, 1997, and Hutchins et al., 1999)
(a) the secretory pathway (soluble vacuolar glycoproteins and integral  membrane
proteins of the vacuolar membrane are co-translationally translocated into the ER
and transit, via vesicular intermediates, to the trans-Golgi network, where they are
sorted away from secreted proteins and further targeted to the vacuole);
(b) endocytosis (degradation pathway of extracellular proteins);
(c) macroautophagy (non-specific degradation of cytosolic components);
(d) microautophagy (specific degradation of cytosolic components);
(e) the cytoplasm to vacuole targeting pathway (Ape1p constitutive targeting
pathway)
Autophagosomes are 400-900 nm diameter vesicles that could arise from the
invagination of the rough ER. This process is named macroautophagy. (d)
Microautophagy is a selective sequestration at the vacuolar membrane. Invaginations or
finger like protrusions of the vacuolar membrane surround cellular components. For
example, pexophagy is induced during adaptation to glucose of yeast cells, shifted from
oleic acid or methanol. (e) Some resident proteins, in particular a-mannosidase and
aminopeptidase 1, enter this organelle by an alternate mechanism directly from the
cytoplasm (Cvt pathway). Cvt vesicles are about 150 nm in diameter.  (Oda et al., 1996;
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Klionsky et al., 1992; Harding et al., 1995)
Table 1: Type of mutants that affect the vacuolar protein transport
TYPE MUTANTS PHENOTYPE
pep4 deleted gene of proteinase A
(PEP4)
lack many vacuolar hydrolytic enzymes (PrA,
PrB, CPY, Ape1p)(1)
sec secretory protein transport (2) are temperature-conditional mutants and therefore
are incapable of protein secretion under restrictive
conditions
vps vacuolar protein sorting (3) missort and secrete vacuolar hydrolases as their
Golgi-modified precursors; show changes in
vacuolar morphology
vid vacuolar import and
degradation (4)
fail to degrade FBPase in response to glucose
apg
aut
autophagy-defective (5)
autophagy(6)
defective in accumulation of autophagic bodies;
defective in protein degradation, in the vacuoles,
induced by nitrogen starvation
cvt cytoplasm to vacuole targeting
(7)
were isolated as mutants defective in Ape1p
import and maturation, using antiserum against
pro-peptide of pApe1p; Overlap with apg and aut.
vac8 Vac8p‘s gene (VAC8) deleted
(8)
defective in vacuolar inheritance;
defective in protein transport from the cytoplasm
Dvat
vph
Disruption of V-ATPase
encoding genes (9)
missort soluble and  membrane vacuolar proteins;
defective in vacuolar acidification.
(1): Raymond et al., 1992; Hemmings et al., 1981; (2): Stevens et al., 1982;Eakle et al., 1988;
(3): Bankaitis at al., 1986; Banta et al., 1988; (4): Hoffman and Chiang, 1996; (5): Tsukada
and Ohsumi, 1993; (6): Thumm, et al., 1994; (7): Harding et al., 1996; Scott et al., 1996; Baba
et al., 1997; (8): Wang et al., (1998); (9): Klionsky et al., 1992; Yaver et al., 1993.
1.3. Aminopeptidase 1- transport
Aminopeptidase 1 (Ape1p) is a resident vacuolar hydrolase, which catalyses the
removal of leucine from the N-terminus of polypeptide chains.
Ape1p is encoded by a single copy gene, named APE1 (previously LAP4),
located on chromosome XI. It is synthesized in the cytoplasm as a 61-kDa precursor
(pApe1p) of 514 amino acids residues. Upon the post-translationary entry into the
vacuole, pApe1p is matured by the endopeptidases PrA and PrB, yielding first a 55 kDa
intermediate form and then the mature 50-kD form of 459 amino acids (Segui-Real et
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al., 1995). The vacuolar mApe1p forms a homododecameric complex and
dodecamerisation is required for its enzymatic activity. T1/2 for processing is
approximately 45 min under both vegetative and starvation conditions (Klionsky et al.,
1992;  Scott et al., 1996). pApe1p has a long processing time (45 min). It was found to
be assembled into a dodecamer of approximately 732 kDa immediately after synthesis
(T1/2 2 min) and was maintained in the oligomeric form throughout the targeting process
(about 30 min) (Kim et al., 1997).
The vacuolar localisation of Ape1p is independent of the secretory pathway
(Klionsky et al., 1992). The precursor does not receive glycosyl modifications, and
removal of its pro-peptide occurs in a sec-independent manner (Klionsky et al., 1992,
Chang and Smith, 1989). The 45 amino acids precursor sequence forms a helix-turn-
helix structure (Martinez et al 1997; Chang and Smith, 1989). Mutations that disturb
formation of the first helix also abolish pApe1p transport (Oda et al., 1996). The N-
terminus of pApe1p is processed prior to a C-terminal sequence-tag during the vacuolar
import, suggesting that pApe1p is transported into the vacuole by a translocation event
assisted by a putative receptor (Segui-Real et al., 1995). Ape1p’s maturation is inhibited
by low temperatures, which should not happen in a translocation event.  Neither pApe1p
nor the transport incompetent truncated mutants p(D1-16)Ape1p and p((D1-45)Ape1p
are processed in the cytosol. This resistance to cytosolic proteases suggests that pApe1p
is probably folded in the cytosol and that its translocation through the vacuolar
Table 2: Effects of site directed mutations on pApe1p processing/targeting
 (changed accordingly to  M.N.Oda et al, 1996)
Mutation Ape1p Processing Localisation
D3-5; D6-8 Complete block Not determined
D9-11; D12-14; D15-17; D18-20 Complete block Cytosolic
D25-27 wt Not determined
D28-30; D31-33; D34-36 wt Vacuolar
D37-39; D40-42 wt Not determined
Ala11 Complete block Cytosolic
Ala 34 wt Vacuolar
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membrane may require prior unfolding (Segui-Real et al., 1995).
Vacuolar protein degradation is enhanced under glucose starvation conditions in
rich (YPD) or for nitrogen starvation in minimal (MV) media. Complementation
analysis of yeast mutants defective in Ape1p maturation revealed that autophagy
mutants are also defective in pApe1p transport suggesting that macroautophagy and
Ape1p transport utilise many of the same molecular components. This is surprising
because Ape1p targeting is known to be a selective and constitutive event, whereas
macroautophagy is clearly non-selective and is induced by starvation. Ape1p import
was examined by immuno-electron microscopy in both rich media and starvation
conditions, to resolve the apparent discrepancy of how Ape1p could be transported both
selectively and constitutively by macroautophagy, a mechanism thought to be non-
selective and require starvation induction (Baba et al., 1997). In nutrient-rich conditions
in wild-type cells cytosolic pools of pApe1p appeared clustered into specific regions of
the cytosol called Cvt complexes. The clustered pApe1p appeared enwrapped in double-
membrane structures called Cvt vesicles that were similar in appearance to
autophagosones. The Cvt structures observed in nutrient-rich conditions were
morphologically similar to the corresponding vesicular structures formed under
starvation conditions with a few exceptions (Baba et al., 1997). The contents of Cvt
vesicles stained densely and appear to be devoid of ribosomes, whereas the contents of
autophagosomes are indistinguishable from bulk cytosol (Baba et al., 1994; Baba et al.,
1997). The diameters of the two types of vesicles are different: autophagosomes were
400-900 nm in diameter, whereas the Cvt vesicles measured just about 150 nm. These
data suggest that during growing conditions, vesicles are formed and those carry
specific components, such as pApe1p, to the vacuole. Upon shifting to starvation, these
vesicles are triggered to increase in size and gather in bulk cytosolic components in
addition to their normal selective cargo.
The origin of the membrane, which may enwrap the pApe1p complex, is
unknown as is the nature of the receptor, which may assist at some points in the pApe1p
transport. The possibility of uptake of the monomer or oligomer pApe1p from the
cytosol by a specific process, like microautophagy is not excluded. Macroautophagy as
well as microautophagy and translocation may contribute to cytoplasm to vacuole
transport of pApe1p.
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Recently, the genes that complement several of the autophagy mutants have
been cloned and sequenced. Apg5p (Kametaka et al., 1996), Apg13 (Funakoshi et al.,
1997) and Aut1p (Schlumpberger et al., 1997) are predicted to be hydrophilic proteins
of 33 kDa, 83 kDa, and 36 kDa, respectively. None of these polypeptides display
significant homologies to other proteins in the database. Apg1p is predicted to be a
novel serine/threonine kinase of 102 kDa (Matsuura et al., 1997). Through the
investigation of Ape1p transport, a vacuolar t-SNARE Vam3p was identified (Darsow
et al., 1997). This protein is required for the vacuolar delivery of vesicles originating
from the endosome and is likely to be a component of the general recognition/fusion
machinery at the vacuolar membrane. cvt4 and cvt8, alleles of vam4/vps39 and
vam2/vps41 (Harding et al., 1995) , respectively, have been found to be members of a
protein complex on the vacuole membrane (Nakamura et al, 1997). The vacuole Vp18p
has been shown to be required for the delivery of both Cvt vesicles and autophagosomes
to the vacuole (Scott et al., 1997; Rieder et al., 1997). A tubulin associated protein
complex of Aut2p and Aut7p is required for vacuolar uptake of autophagosomes (Lang
et al., 1998). Aut4p and Aut5p are essential for lysing autophagic vesicles in the
vacuole (Thumm et al., 1999). A unique covalent-modification system was found to be
essential for autophagy: the carboxy-terminal glycine residue of Apg12 (186 amino acid
protein) is conjugated to a lysine at residue 149 of Apg5 (294 amino acid protein).
Among the apg mutants, apg7 and apg10 were found to be unable to form an
Apg5/Apg12 conjugate. The sequence of APG7 revealed that Apg7p is a ubiquitin E1-
like enzyme. The conjugation of Apg5/Apg12 could be reconstituted in vitro and
showed dependency on ATP (Mizushima et al, 1998). Investigation of the function of
Apg7p as an Apg12p-activating enzyme indicated that Apg12p might interact with
Apg7p via a thioester bond, a mechanism already known for the ubiquitin conjugated
system. Mutational analysis of Apg7p suggested that Cys507 of Apg7p is an active site
cysteine and that the ATP-binding domain and the cysteine residue are essential for the
conjugation of Apg7p with Apg12p. Cells expressing mutant Apg7p, Apg7pG333A, or
Apg7pC507A showed defects in autophagy and cytoplasm to vacuole targeting of
pApe1p (Tanida et al., 1999; Takahiro et al., 1999). Apg16 forms homo-oligomers and
is a linker molecule forming an Apg12p-Apg5p-Apg16p multimeric complex
(Mizushima et al, 1999).
2. AIMS OF THE PRESENT STUDY
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2. AIMS OF THE PRESENT STUDY
The sorting and delivery pathways of pApe1p from the cytoplasm to the vacuole
are controversly discussed: an incorporation into a cytoplasmatic vesicle followed by
fusion with the target organelle as seen in autophagy, or a direct membrane
translocation via an active transport protein or by membrane invagination as a result of
binding of pApe1p to a receptor molecule.
In order to identify new factors required for transport of pApe1p, the first goal
was to develop a new genetic screen in yeast Saccharomyces cerevisiae based on the
enzymatic activity of the transported and matured dodecameric pApe1p, thus extending
the screen to the final stage of pApe1p transport. EMS-mutagenesis and yeast genetics
should be used to clone new genes required for cytoplasm to vacuole transport.
The second goal was to characterize these mutants biochemically, to learn more
about the mechanism of pApe1p transport.
3. MATERIALS AND METHODS
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3. MATERIAL AND METHODS
3.1. Material
3.1.1. Chemicals
Acetic acid (Merck)
Acetone, p.a. (Merck)
30% Acrylamide / 0.8% Bisacrylamide in H2O (Roth)
Agar (Sigma)
Agarose (Gibco BRL)
Ammoniumsulfate,  (NH4)2SO4 (Merck)
Ammonium persulfate (APS) (Merck)
Amino acids and nucleosides (Serva):
- Adenine, hemisulfate salt (MW=182.2)
- L-Arginine · HCl (MW=210.7)
- L-Aspartic acid*(MW=133.1)
- L-Glutamic acid (MW=147.1)
- L-Histidine · HCl (MW=209,6)
- L-Isoleucine (MW=131.2)
- L-Leucine (MW=131.2)
- L-Lysine · HCl (MW=182.7)
- L-Methionine (MW=149.2)
- L-Tyrosine (MW=181.2)
- L-Phenylalanine (MW=165.2)
- L-Serine (MW=105.1)
- L-Treonine (MW=119.1)
- L-Tryptophan (MW=204.2)
- Uracil (MW=112.1)
- L-Valine (MW=117.2)
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Bacto Agar (Difco)
Bacto-Peptone (Difco)
Bromphenolblue (BioRad)
1-Butanol p.a. (Merck)
Calciumchloride, CaCl2 (Merck)
Citric acid monohydrate, C6H8O7 ·H2O (MW=210,14) (Merk)
Chloroform p.a. (Merck)
Coomasie, Serva Blue R (Serva)
Diethyl pyrocarbonate (DEPC) (Sigma)
Dextransulfat (Pharmacia)
Dimethylsulfoxide (DMSO) (Merck)
Dithiothreitol (DTT) (Serva)
o-Dianisidine, C14H16N2O2·2HCl (Sigma)
e-Amino-n Caproic Acid, C6H13NO2 (MW=131.2) (Sigma)
Ethanol p.a. (Merck)
EDTA, C10H14N2Na2O8 · 2H2O (MW=372.24) (Merck)
Ethidium bromide (MW= 394.32) (Serva)
Ficoll (MW = 378.5) (Sigma)
Formaldehyde (Merck)
(D+) Glucose Monohydrate (Merck)
Glycerol (C3H8O3; 1 l =1.26 kg) (Merck)
HEPES ( N-2-Hydroxyethylpiperazin-N-2-ethansulfonsäure) (Serva)
Isoamylalcohol (Merck)
Lithium Acetate (C2H3O2Li · 2 H2O; MW= 102.0) (Sigma)
Luminol (3-aminophthalhydrazide)  (Fluka)
2-Mercaptoethanol (MW=78.13) (Merck)
Methanol (Merck)
3-[N-Morpholino]propanesulfonic acid (MOPS), C7H15NO4S (MW=209.3) (Serva)
OptiPrep Density Gradient Medium (60% w/v solution of Iodixanol) (Sigma)
p-Coumaric acid (Sigma)
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Perhydrol, 30% H2O2 (Merck)
Phenol (Merck)
Piperazine-N,N’-bis[2-etanesulfonic acid] (PIPES) (MW=378.5) (Sigma)
Polyethylenglycol (PEG 4000) (BDH Laboratory, Engl.)
Phosphoric acid, 85%  H3PO4 (Merck)
Potassium Acetate (Merck)
2-Propanol  p.a. ( Merck)
Sephadex G-50 (Pharmacia)
Sodium Acetate, CH3COONa (MW=82.03) (Merck)
Sodiumcitrat (Merck)
Sodium dodecyl sulphate (SDS), C12H25O4SNa (M=288.04) (Sigma)
Sodiumhydroxide (MW=40.00) (Merck)
Sodiummonohydrogenphosphate Na2HPO4 ·2H2O (MW=177.99) (Merck)
Sodiumdihydrogenphosphate NaH2PO4 ·H2O (MW=137.99) (Merck)
Sorbitol, C6H14O6 (MW=182.2)(Sigma)
Sucrose (Merck)
Sulphuric acid 95-97% (Merck)
N’N’N’N Tetramethylethylendiamine (TEMED) (Serva)
Trichloracide (TCA) (MW=163.39) (Merck)
Tris-Base (Tris) (MW=121.14) (Biomedicals, INC)
Tryptone (Difco)
Yeast extract (Difco)
Yeast Nitrogen Base w/o Amino Acids (Difco)
3.1.1.1. Antibiotics
Ampicillin trihydrate (Serva)
3.1.1.2. Enzymes
L-amino acid oxidase (type II, crude dried venom from Bothrops atrox; 0.64 U/mg
solid) (Sigma)
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b-Glucoronidase (from Helix pomatia; 100 U/µl) (Sigma)
Horseradish peroxidase (200 purpurogallin U/mg solid) (Sigma)
Lyticase from Oerskovia xanthineolytica (>7000U/mg; 0.5mg/ml) (Boehringer
Mannheim)
Lysozyme (from hen’s egg white; 100000 U/mg) (Merk)
Proteinase K (from Tritirachium album) (Boehringer, Mannheim)
Phosphatase, alkaline from calf intestine (1U/µl, S.A. 2000 U/mg) (Boehringer,
Mannheim)
Restriction endonucleases (Boehringer, Gibco BRL, New England Biolabs)
RNase A (Boehringer, Mannheim)
Zymolyase 20T (from Arthrobacter luteus) (Seikagaku Corporation, Japan)
T4-DNA-Ligase (New England Biolabs)
Trypsine (from bovine pancreas; 48 U/mg) (Serva)
3.1.1.3. Detergents, Substrates and Inhibitors
Substrates:
- H-Leu-b-Naphtyl Amid (H-Leu-b-NA) (MW=256.4) (BACHEM)
- H-Leu-p-Nitroanilid (H-Leu-p-NA) (MW=256.4) (BACHEM)
- Z-Gly-Leu (BACHEM)
Detergents:
- Tween 20 (Serva)
- Tween 40 (ICN)
- Triton X-100 (Boehringer Mannheim)
Inhibitors:
- 5 - inhibitor mix, in DMSO:
0.75 mg/ml Antipain
0.25 mg/ml Chymostatin
0.25 mg/ml Elastin
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5 mg/ml Pepstatin
1.25 mg/ml Leupeptin
- PMSF ( phenylmethyl-sulfonyl-fluoride) 100x: 200 mM in DMSO
- EDTA (Sigma)
- Natriumazide (NaN3) (Sigma): 10% in H2O
3.1.1.4. Standards
Standards for proteins:
- Bovine Serum Albumin Fr. V pH 7.0 (BSA)(MW=67000) (Serva)
- Ovalalbumine (MW=45)
- Thyroglobuline (MW=669)
- RainbowTM protein molecular weight markers (Amersham Life Science)
- Prestained protein molecular weight markers (Calbiochem)
- BenchMarkTM prestained protein ladder (Gibco BRL)
Standards for DNA:
1kb DNA-Ladder (Gibco BRL)
3.1.1.5. Radioactive substances
a- [32P]-dCTP, 3000Ci/mmol (Ammersham)
3.1.1.6. Kits and Nucleotides for work with Proteins, DNA and RNA
RNeasy Mini Kit (Qiagen, Hilden)
Super SignalTM CL-HRP Substrate System (Pierce, Rockford/USA)
Dye Terminator Cycle Sequencing Kit (Applied Biosystems, USA)
Megaprime DNA Labelling mix
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3.1.1.7. Antibodies
Table 3: Antibodies used for biochemical characterisation of via mutants
NAME DILUTION  TYPE SOURCE
Goat anti Rabbit-
HRP
1:10000 second antibody Dianova, Hamburg
Anti-APE1 1:1000 -first antibody
-polyclonal
Dr. P.Schu, Göttingen University
Anti-CPY 1:10000 -first antibody Dr. H.D.Schmidt, MPI
Göttingen
Anti-a-HK 1:1000 -first antibody Dr. H.D.Schmidt, MPI
Göttingen
Anti-Ssa1/Ssa2 1:10000 -first antibody Dr. E.Craig, Chicago University
Anti-aPcs60p 1:10000 -first antibody Prof. R. Erdmann, Berlin
University
3.1.2. Yeast strains
Table 4: Yeast strains used for generation and selection of via mutants
STRAINS CHARACTERISTICS SOURCE
SEY6211 MATa, ura3-52, his3D1, leu2-3,-112, trp1-
289, suc2-D9, ade
Prof.Dr. S. Emr,
UCSD, California, USA
II-17 MATa, ura3-52, his3D1, leu2-3,-112, trp1-
289, lap1, lap2, lap3, lap4
Prof.Dr. D.H.Wolf,
University Stuttgart
14 mutants
original EMS-mutants: MATa, Dlap1-4;
pRS/LAP4, trp+
Dr.P.Schu,
Göttingen University
3.1.3. Yeast DNA libraries
Table 5: Yeast DNA libraries used for screening of via10 and via14
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NAME SELECTION
MARKER
SOURCE
YCP 126 leu+ Dr. H.D.Schmidt, MPI Göttingen
pYEP 13 leu+ Dr. H.D.Schmidt, MPI Göttingen
P1-P5 ura+ C. Sengstag, ETH Zürich
3.1.4. Bacteria
Table 6: E.coli used for cloning experiments
NAME GENOTYPE
DH5a F’/endA1 hsdR17 (rk – mk +) supE44 thi-1 recA1 gyrA
XL1Blue
3.1.5. Vectors
pBlueskript KS II+ (Stratagene)
pCS19 (Sengstag, C. (1993) Gene 124, 141-142)
pRS (Sikorski, R.S., and Hieter P., (1989), Genetics 19-27)
3.1.6. Plasmids
Table 7: Plasmids used for cloning experiments
NAME AUXOTROPHY
MARKERS
SOURCE
p313/LAPIV
p314/LAPIV
p701/ SSA2
p703/ SSA1
his+
trp+
leu+
leu+
Dr.P.Schu,
Göttingen University
Dr.M.Horst,
Göttingen University
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p280/Vti1-2µ
p283/Vti1-cen
ura+
ura+
Dr.G.Fischer von Mollard,
Göttingen University
3.1.7. Buffers and stock solutions
All buffers and solutions listed were prepared in bidistilated H2O using chemicals of
highest purity available.
Ampicillin
Stock solution: 25 mg/ml of the sodium salt ampicillin in H2O. Sterilised by
filtration and store in aliquots at –20°C.  Working concentration 50-100 µg/ml.
0.1 M CaCl2
CaCl2.2H2O (14.7 g) dissolved in H2O (Vf =1 litre); autoclaved.
50 x Denhardts
1% Ficoll, 1% Polyvinylpyrolidon, 1% BSA.
1M DTT
DTT (3.09 g) dissolved in H2O (Vf = 20 ml) and stored as aliquots at –20°C.
10 mg/ml Ethidium bromide
Ethidium bromide (0.2 g) dissolved in H2O (Vf = 20 ml). Store at 4°C in dark.
Handle with gloves and avoid inhalation!
0.5 M EDTA
Na2EDTA.2H2O (93.05 g) dissolved in H2O (300 ml). pH adjusted to 8.0 with 10 M
NaOH (cca 25ml). Will not go into solution until about pH=7! Added H20 to 500 ml.
20% D-Glucose
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D-Glucose (100 g) dissolved in H2O (Vf = 500 ml). Sterilised in autoclave.
100mM IPTG (isopropyl-b-D-thiogalactopyranoside)
23.8 mg IPTG in 1 ml H2O.
NaPi 0.1 M pH 7.4
Prepare 100 ml of NaH2PO4 0.5 M (6.89 g in H2O) and 100 ml of Na2HPO4 0.5 M
(8.89 g in H2O). Correct the pH of one with the other one. For 50 ml NaPi 0.1 M pH
7.4 dilute 10 ml NaPi 0.5 M pH 7.4 with 40 ml H2O.
10M NaOH
NaOH (200 g) in dissolved H2O (Vf = 500 ml).
ssDNA stock solution
10 mg/ml in H2O.
sonicated and denatured for 5 min at 95°C; chilled on ice.
1.2 M Sorbitol, 50 mM Tris/Cl pH 7.5, 10 mM EDTA  pH 8  (STEDTA)
54.66 g Sorbitol
5 ml     EDTA 0.5 M pH 8
12.5 ml            Tris/Cl 1M pH 7.5
till 250 ml H2O
0.8 M Sorbitol in TE
0.8 ml      Tris/Cl 1M pH 8
0.16 ml EDTA 0.5 M pH 8
64 ml      Sorbitol 1M (or 11.66 g Sorbitol)
till 80 ml with H2O
3 M Sodium acetate
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Sodium acetate.3H2O (40.8 g) dissolved in H2O (100 ml). Adjust pH to 5.2 with
 3M acetic acid.
20% SDS
SDS (20 g) dissolved in H2O (Vf = 100 ml). Avoid breathing dust!
50 % TCA
50 g in 100 ml H2O
1M Tris/HCl:
Tris base (121g) dissolved in H2O (800 ml). Adjust to desired pH with concentrated
HCl. Add H2O to 1 litre.
50 x TAE
2 M Tris-Cl
0.1 M EDTA, pH 8.0 (correction with CH3COOH)
1 x TE
10 mM Tris/Cl pH 7.5
1mM EDTA
3.2. Sacharomyces cerevisiae protocols
3.2.1.             Yeast cultures
3.2.1.1. Media for yeast culture
YPD-Medium
1% Yeast Extract
2% Bacto-Peptone
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2% D-Glucose
2% Bacto-Agar
For preparation of 1000 ml solid YPD-medium, Yeast Extract (10 g), Bacto-Peptone
(20 g) and Bacto-Agar (20 g) were dissolved in 900 ml ddH2O and sterilised by autoclaving.
Afterwards, 100 ml of 20% autoclaved D-Glucose stock solution was added. For preparation
of liquid YPD-medium, bacto-agar was omitted.
GNA-Medium (pre-sporulation medium)
1 % Yeast Extract
3 % Nutrient Broth
5 % D-Glucose
2 % Bacto-Agar
For preparation of GNA-Medium (500 ml) Yeast Extract (5g), Nutrient Broth (1.5 g)
and Bacto-Agar (10 g) were dissolved in ddH2O, to final volume of 375 ml and sterilised.
Afterwards, 125 ml of 50% D-Glucose stock solution were added.
Acetate-Medium (sporulation medium)
0.125%  Yeast Extract
1.47%   Potassium Acetate
0.1% D-Glucose
2% Bacto-Agar
Acetate-Medium (500 ml) was prepared from Yeast Extract (0.625 g), Potassium
Acetate (7.35 g) and Bacto-Agar (10 g) dissolved in 497.5 ml ddH2O and sterilised.
Afterwards, 2.5 ml of 20% D-Glucose stock solution were added.
Synthetic minimal medium (MV)
0.67 % Bacto-yeast nitrogen base w/o amino acids
2 % (or 0.5 %) D-Glucose
2 % Bacto-Agar
as needed Amino acids
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For preparation of synthetic minimal medium (600 ml) Bacto-yeast nitrogen base w/o
amino acids (4 g) and Bacto-Agar (12 g) were dissolved in ddH2O and sterilised. D-Glucose
(20% stock solutions) and amino acids mixtures were prepared separately and added as
required. In table 7 are listed amino acids and their concentration on synthetic complete
medium. For preparation of liquid SD-medium, bacto-agar was omitted.
YPO-Medium
0.15%  Oleic acid
0.015% Tween 40
0.3%  Yeast Extract
0.3%  Peptone
0.7%  KH2PO4  
For preparation of liquid YPO-medium (500 ml) Yeast Extract (1.5 g), Bacto-
Peptone (1.5 g), KH2PO4 (3.5 g) and Tween 40 (75 µl) were dissolved in ddH2O at final
volume and sterilised. Oleic acid (750 µl) was added and medium was stored protected from
light.
Table 8: Amino acids, nucleoside and their concentration in synthetic minimal medium
 (MV)
Amino acids and nucleoside
(*=no autoclaving)
Final concentration in
SD (mg/l)
Storage of
stock solution
         Adenine sulphate
L-Tyrosine
L-Phenylalanine
L-Glutamic acid
L-Aspartic acid*
L-Methionine
                 20
30
50
100
100
20
At room temperature
         L-Arginine - HCl
L-Isoleucine
L-Lysine - HCl
L-Valine
L-Treonine*
L-Serine
Uracil
L-Leucine
L-Tryptophan
L-Histidine
                 20
30
30
150
200
375
20
30
20
20
At-20°C
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3.2.1.2. Inoculation and growth of yeast cultures
Yeast is non-pathogenic and therefore can be handled with few precautions. Yeast
cultures were grown from a few single colonies picked from fresh selective-medium plates, at
30°C on YPD or MV media.
Usually, a pre-culture was prepared to inoculate the final culture. For pre-cultures single
colonies were inoculated into 1-5 ml of the appropriate media and grown for 12-16 hours.
High aeration was achieved by vigorously shaking (for example, at 200 rpm) and the culture
volume was less than one third of the flask volume.
In general, the strains reached a maximum optical density OD600 = 2.5 in YPD. Haploid
strains had a doubling time of 120 min to 210 min depending on the strain and culture media.
3.2.1.3. Yeast-strain preservation
Yeast strains have been stored for short periods of time at 4°C, on YPD medium in
Petri dishes. Passages of the stock are recommended in 2 to 4 weeks intervals. Indefinitely,
yeast strains are stored in 15-30% (v/v) glycerol at –80°C. To preserve yeast-strains
indefinitely, either a fresh YPD-liquid culture of cells grown in appropriate media is mixed with
sterile glycerol, or fresh cells grown on selective media are scraped up and suspended in the
sterile YPD-glycerol solution. The caps are tightened and the vials shaken before freezing.
Transferring a small portion of the frozen sample to a YPD plate can revive yeast. (Guthrie
and Fink, 1991)
3.2.2.       Tetrad analysis
3.2.2.1. Sporulation of yeast strains on plates
The products of a single meiosis in yeast are 4 haploid spores (the tetrad) hold
together in a single ascus. Meiosis is induced by shifting cells to a medium without a source of
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nitrogen and with acetate as the sole carbon source. Meiosis is not induced in H2O (Guthrie
and Fink, 1991).
To achieve sporulation cells were grown on YPD-plates for 2-3 days. Then the cells
were spread on pre-sporulation media (GNA), so that one clone covered about a quarter to
one half of a plate and incubated regularly about 2 days. The cells should form a thick
confluent layer. Afterwards, all the cells were transferred from GNA-plates onto sporulation
medium (Acetate medium) in a way that they were spread over an area of the size they were
grown on the GNA-plates. The first spores could appear on sporulation medium after 3-5
days at 30°C.
3.2.2.2. Micro-manipulation and dissection of ascospores
Sporulated cultures consist of a mixture of unsporulated vegetative cells, four-spore
asci, three-spore asci, etc. Dissection of asci requires the identification of four-spore asci and
the relocation of each of the four ascospores to separate positions on an agar plate where they
form isolated spore colonies. The procedure requires digestion of the ascus wall without
dissociating the four spores from the ascus. The relocation and transfer of ascospores,
zygotes, and vegetative cells were carried out, as shown in figure 3, on agar surfaces with a
Figure 3: Transfer of the four ascospores from an agar surface to the platform of a
   micro-needle
   (modified according to Guthrie and Fink, 1991)
  1 2 3
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optic glass fiber micro-needle (Singer Instruments) mounted in the path of a microscope
(Zeiss) objective and a micromanipulator.
To separate spores, sporulated cells were re-suspend in 100 µl H2O. 2µl of b-
glucoronidase (100 U/µl) were added. The suspension was incubated 20 min at 30°C and
then stored at 4°C up to one week. Cells were spread on one side of a YPD-plate. With a
needle controlled by the micromanipulator, spores were isolated from the surrounding
unsporulated cells, freed from the surrounding asci-wall and the spores were aligned as shown
in figure no. 3-2 and labelled A, B,C and D.
Figure 4: The steps for sequentially separating the cluster of four ascospores on Petri
   dishes (according to Guthrie and Fink, 1991)
3.2.2.3.      Mating-type determination
Mating-type determination based on complementation of auxotrophic markers
When haploid cells of opposite mating type and carrying different markers for
auxotrophy are co-cultured, they participate in a mating process. The result of mating is a
diploid that carries both sets of markers for auxotrophy.
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One strain of type a/trp+ is normally cultured on MV-Trp, and a strain of type a/his+
is normally in cultured on MV-His. When, on a YPD-plate, a few young cells of type
MATa/trp+ were physically put in contact with a few young cells of type MATa/his+, after 6-
12 hours, these cells should mate. A mixture of MATa-type, MATa-type and
 MATa/a  -  type cells is formed. In order to separate the diploids from the haploid -
“parents”, the cells were plated on double selective media, MV-Trp\His.
Mating-type determination by tester-strain RC828 (MATa)
When hundreds of cells are assayed for mating-type, as is the case during tetrad
analysis, the best choice to distinguish between MATa  -cells from those being MATa or
MATa/a  is a method based on a pheromone test.  This method is based on the fact that a-
factor secreting cells induce a growth arrest in a cells. The tester strain RC828, MATa is not
able to leave the growth arrest in G1and is therefore not able to grow in the vicinity of a-
factor secreting cells.
RC828 (MATa) grown over night in YPD-liquid at 30°C was diluted 1:10 or 1:100 in
the overlay-agar and the mixture kept liquid at 45°C and spread over YPD-plates. After the
agar turned solid, strains to be tested were transferred on the overlay agar by an applicator-
needle. The plates were incubated at 30°C for 1-3 days until the growth – inhibition of the
tester-strain became visible. If colonies secrete pheromone, they inhibit the growth of the
tester-strain in the overlay agar. This keeps the overlay- agar around the colonies transparent.
Colonies that do not produce pheromone are presumably of the same mating type as the tester
strain (here a) or a/a - diploids.  This assignment was confirmed by determining whether they
can sporulate or by mixing with a-type cells and monitoring the mating process
microscopically, as described further.
Table 9: Rule for mating-type determination based on pheromone tests
Rule1: Halo strain tested of a-type
tester-strain
RC828
(MATa)
Rule2: Non-halo strain tested of a/a or a-type;
further tests are required
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Overlay-Agar:
0.8%  Agar
0.1M  Na-Citrat, in YPD pH 4.5
The pH of 0.1M Na-Citrat in YPD (100 ml) was corrected with 0.1M Citric acid in
YPD (100 ml). 0.8% Agar (w/v) was added and sterilised.
Whenever a few number of strains were assayed for mating type a method based
on observations of morphology changes (figure 5) was applied. The method was used to
     Figure 5: The conjugation process in S. cerevisiae
        (according to Berlin et al., 1991)
MATa mixed with MATa cells, mutually stimulate each other via secreted peptide
pheromones to arrest growth in G1, induce transcription of mating-specific genes
and form projections, that give the cell a pear shape, in the direction of perspective
mating partners. Contacts lead to a rapid reorganisation of the cell surface and
mixing of cytoplasmic contents. Nuclear fusion follows cellular fusion, and the
diploid cell commences vegetative growth.
a-Factor
a-Factor
MATa MATa
Haploid vegetative cell cycle
Cell cycle arrest
Projection formation
Cell contact, aglutination
Cellular fusion
Nuclear fusion
Start of diploid vegetative cycle
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confirm the isogenity of a cell line, additional test to distinguish between a and a/a  strains after
pheromone tests, determination of the mating-type when the test based on complementation of
nutritional requirement could not be performed.
On a YPD-plate, cells were spread with an applicator-needle as patches together with
an a-tester strain and an a-tester strain. A third part of the plate was used for mixing the cells
with each tester strain. The cells were grown for 1-2 days before mixing. After mixing, within
5-8 hours, they were analysed with an optical microscope (20x- 40x) for the formation of the
diploid yeast zygote.
3.2.3. Ethylmethane sulphonate (EMS) - mutagenesis
EMS-mutagenesis was performed using the mutagenic agent ethylmethane sulphonate
(EMS), an alkylating agent which induces high frequencies of base-pair substitution, almost
exclusively at G.C sites.
A stationary yeast culture of II-17 transformed with pRS/314 LAP4 (trp+) was
harvested and the cell pellet was re-suspended in 3 ml 0.1 M NaPi pH 7.4. 100µl EMS were
added and the suspension was incubated for 30 min at 30°C. Cells were washed 3 times with
H2O, plated onto YPD plates and incubated for three days at 30°C.
3.2.4. Transformation of yeast cells
3.2.4.1. Yeast transformation by lithium-acetate method
The most frequently used transformation protocol for introduction of
plasmid DNA into yeast cells is the lithium acetate procedure. This method is based on the fact
that alkali cations make yeast competent to take up DNA. After yeast is briefly incubated in
buffered lithium acetate, transforming DNA is introduced with carrier DNA. Addition of
polyethylene glycol (PEG) and heat shock trigger DNA uptake. The yeasts are then plated on
selective media.
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Making yeast competent cells for lithium-acetate transformation
Two days before starting the experiment cultures were inoculated in 50 ml YPD-
medium. The cells were grown overnight at 30°C, to OD600= 0.6-1.2. If higher efficiency was
desired the cells were diluted to OD600= 0.3-0.4 in fresh YPD medium and grown for another
1 to 2 generations (2 to 4 hours). The cells were harvested at 3000 rpm for 5 min in Heraeus
centrifuge and then washed 3-4 times with sterile H2O. The cell pellet was re-suspended in 1.5
ml LiOAc/TE 1x and kept on ice up to 14 hours. Minimum time required to prepare
competent cells is 2 hours, at 30°C.
Lithium acetate transformation
For each transformation, 200 µl suspension of yeast competent cells were mixed
gently with 5 µg plasmid DNA and 100 µg ssDNA in a sterile 1.5 ml centrifuge tube. The
mixture was incubated at 30°C for 15-30 min. Further, fresh prepared 40% PEG 4000 in
LiOAc/TE (1.2 ml) was added to each tube. The tubes were mixed by inverting or gentle
pipetting with a 1 ml tip and then incubated for 30 min at 30°C with gentle agitation or inverted
occasionally. After heat shock for 5 min at 42°C and brief cooling on ice, the cells were spun
down by three times centrifugation for 5 seconds each. The supernatant was removed and the
cell pellet was re-suspended gently in 0.8M sorbitol-LiOAc/TE. Cell suspension (200 µl) was
spread onto appropriate selection plates. The plates were incubated at 30°C for a minimum of
2-3 days.
LiOAc/TE 1x:
1 vol. 10x TE pH 7.5
1 vol. 10x LiOAc pH 7.5
8 vol. H2O
0.8M Sorbitol in LiOAc/ 0.1M TE  (1x):
8 vol. 1M Sorbitol
1 vol. LiOAc/ 1M TE
1 vol. H2O
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10x LiOAc pH 7.5:
1M LiOAc pH 7.5, corrected with CH3COOH
3.2.4.2. Yeast transformation by electroporation
When limiting quantities of transforming DNA were available, or a higher
transformation efficiency was desired, method of choice to bring plasmid DNA into yeast cells
was electroporation.
Electroporation of plasmid DNA into electro-competent yeast cells was done using
the Stratagene Electroporator 1000.
Electrocompetent cells were prepared from 250 ml early exponentially grown cultures
in YPD. The cells were harvested at 5000 rpm in JA-10 rotor of Beckman centrifuge, for 5
min, at 4°C.  The pellet was washed twice with 250 ml and 125 ml ice-cold H2O,
respectively, re-suspended in 10 ml ice-cold 1M sorbitol and harvest at 5000 rpm using a JA-
20 rotor of Beckman centrifuge, for 5 min at 4°C.  The cells were re-suspended in 600-800
µl ice-cold 1M sorbitol and used for direct work or stored at 4°C up to one week.
Using the Electroporator 1000 for yeast transformation, field strength of  7.5
kV/cm were required to obtain maximum efficiency. DNA must be free from salt. The cells
must be kept cold during the entire electroporation procedure.
Plasmid DNA (0.1 µg in less than 5 µl) was added to electrocompetent cells (65 µl)
in a microcentrifuge tube. Cell - DNA mixtures were transferred to a pre-chilled cuvette and
incubated 5 min on ice. The outside of the cuvette was dried, then the cuvette was inserted
into cuvette holder and placed into the electroporator. After the pulse, the cuvette was
removed and 1 ml of cold 1M sorbitol was added immediately. Various aliquots were plated
onto selective plates containing 1M sorbitol.
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3.2.5. Extraction of plasmid DNA from yeast
Extraction of plasmid yeast DNA was done either from a stationary liquid culture
(2 ml) in YPD-medium or from cells of up to three SD-plates. Starting with a liquid culture, the
cells were harvested at 13000 rpm, in an Eppendorf centrifuge, for 2 min. The pellet was re-
suspended in lysis buffer (250 µl), with 300 mg glass beads and vortexed for 2 min. To
remove proteins, phenol (250 µl) was added, mixed by vortexing for at least 2 min and
centrifuged at 13000 rpm, for 5 min, at 4°C. The aqueous layer (about 200µl) was transferred
into a new microcentifuge tube. If necessary steps 3 and 4 were repeated 1-2 times. Further,
phenol: chloroform: isoamylalcohol (25: 24: 1, 200µl) was added and mixed as before. After
centrifugation at 13000 rpm for 5 min at 4°C, the aqueous layer was transferred to a new
 of the supernatant was used for transforming directly 200 µl of E.
coli (XL1Blue) - competent cells.
Whenever the quality of DNA was not sufficient, the plasmid DNA was further
purified. Two methods were used: either as described for mini-preparation of plasmid DNA
from E.coli (with a Qiagen-kit: applying DNA solution on a QIAprep spin column, washing
and elution steps) or by precipitation with ethanol in the presence of 300 mM sodium acetate
(1 vol. DNA solution mixed with 1/10 vol. of sodium acetate 3M. EtOH 100%  added to final
concentration of 70%, the mixture incubated for 30 min at  –20°C. DNA was pelleted and
washed with 80% ethanol).
The DNA was stored in TE at –20°.
Lysis buffer:
10 mM Tris/Cl, pH 8
100 mM NaCl
1mM EDTA, pH 8
1% SDS
2% Triton X-100
Lysis buffer was prepared from appropriate stock solutions, as follows 1M Tris/Cl pH
8 (0.5 ml), 5M NaCl (2.5 ml), 0.5M EDTA pH 8 (0.1 ml), 20% SDS (2.5 ml), 100% Triton
X-100 (1 ml), H2O (to final volume of 50 ml), and sterilised.
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3.3.  Escherichia coli protocols
3.3.1.       E. coli culture
3.3.1.1. Media for bacteria culture
LB-Agar:
1% Bacto-Tryptone,
0.5% Bacto-Yeast- Extract
0.5% NaCl
1.5% Agar
To prepare LB-Agar (1000ml), Bacto-Tryptone (10g), Bacto-Yeast- Extract (5g),
NaCl (5g) and agar (15g) were dissolved in H2O. The pH was adjusted to 7.4 with 1N NaOH.
After sterilisation and cooling to 50°C antibiotics were added if desired.
LB (Luria-Bertani)-Medium:
1% Bacto-Tryptone,
0.5% Bacto-Yeast- Extract
0.5% NaCl
To prepare LB-medium (1000ml), Bacto-Tryptone (10g), Bacto-Yeast- Extract (5g)
and NaCl (5g) were dissolved in H2O. The pH was adjusted to 7.4 with 1N NaOH and
afterwards medium was autoclaved.
3.3.1.2. Inoculation and growth of bacterial cultures
Bacteria cultures were grown from a single colony picked from selective plates.
For pre-cultures single colonies were inoculated into 1-5 ml of the appropriate media
and grown with vigorous shaking for 12-16 hours. Bacteria double each 30 min.
3. MATERIALS AND METHODS
______________________________________________________________________
32
3.3.1.3. Bacteria-strains preservation
Strains were preserved for short time at 4°C, on selective medium plates (up to 4-6
weeks). Long time storage was achieved by freezing in the presence of cryo-protectants such
as glycerol (15-30%) or DMSO (5-7%). Cultures were stored at –80°C. Recovery of the
culture is done by removal of a few ice crystals into a fresh LB medium suitable supplemented.
Repeated freezing and thawing of the stocks reduce viability.
3.3.2.    Isolation of plasmid DNA from E.coli
3.3.2.1. Midi-preparation with Qiagen-kit
Midi-preparation with Qiagen-kit allows preparation of up to 100 µg of high- or
low-copy plasmid DNA using a QIAGEN-tip-100, when it is started from maximum culture
volumes of 25 ml for high-copy plasmid DNA and 100 ml low-copy plasmid DNA. The
buffers used during the procedure are listed in the table 10.
A pre-culture of 2-5 ml LB medium containing the appropriate selective antibiotic was
inoculated with single colony from a streaked selective plate and incubated for about 8 hours
at 37°C with vigorous shaking. The pre-culture was diluted 1/500 to 1/1000 into selective LB
medium and let grow at 37°C for 12-16 hours with vigorous shaking. The culture should reach
a cell density of approximately 1 x 109 cells per ml. The bacterial cells were harvested by
centrifugation at 9000 rpm for 15 min at 4 °C in a Beckman JA 10 rotor and the supernatant
removed. The bacterial pellet was completely re-suspended in buffer P1 (4 ml, containing
RNase A). Buffer P2 (4 ml) was added, the sample was gently mixed and incubated at room
temperature for 5 min. After addition of chilled buffer P3 (4 ml), the sample was incubated on
ice for 15 min. After centrifugation for 30 min at 4°C at 13000 rpm in a Beckman JA-20 rotor
a clear supernatant, containing plasmid DNA was removed. The sample was loaded onto a
QIAGEN-tip100 equilibrated with buffer QBT (4 ml) by gravity flow. The QIAGEN-tip was
twice washed with 10 ml each buffer QC. Buffer QF (5 ml) was used to elute DNA. The
DNA was precipitated by mixing with 0.7 volumes isopropanol at room-temperature and
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recovered by centrifugation for 1 hour (at 4°C) at 12000 rpm in a Beckman JA20 rotor. The
DNA pellet was washed with 70% ethanol, air-dried, and dissolved in a suitable volume of
buffer (e.g. TE pH 8.0, or 10 mM Tris.Cl pH 8.5).
Table 10: Composition of  the buffers used for Midi-preparation of plasmid DNA from
   E.coli using a Qiagen-kit
BUFFER COMPOSITION STORAGE
P1
(re-suspension buffer)
50 mM        Tris.Cl pH 8.0
10 mM        EDTA
100 µg/ml   RNase A
4°C, after addition of
RNaseA
P2
(lysis buffer)
200 mM      NaOH,
1%              SDS
room temperature
P3
(neutralisation buffer)
3 M             Potassium Acetate pH 5.5 room temperature
or 4°C
QBT
(equilibration buffer)
750 mM     NaCl;
50 mM       MOPS pH 7.0
15%           Isopropanol
0.15%        Triton X-100
room temperature
QC
(wash buffer)
1 M            NaCl
50 mM       MOPS, pH 7.0
15%           Isopropanol
room temperature
QF
(elution buffer)
1.25 M       NaCl
50 mM       Tris.Cl, pH 8.5
15%           Isopropanol
room temperature
TE 10 mM       Tris.Cl, pH 8.0
1 mM         EDTA
room temperature
3.3.2.2. Mini-preparation of plasmid DNA from E.coli
Method with STET-buffer
Plasmid DNA preparation from E.coli started from 1.5-2 ml (mini-preparation)
o/n liquid culture in LB-medium with ampicillin. The cells were harvested at 12000 rpm for 2
min in microcentrifuge and the pellet was re-suspended in STET-buffer (350 µl). STET-buffer
containing 50000U/ml lysozyme (350 µl) was added, mixed and placed immediately at 95°C
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for 3 min. After 5-10 min shock on ice and centrifugation at 14000 rpm for 10 min in a table-
top centrifuge, the supernatant was removed and the pellet was dried at room temperature,
and re-suspended in 50 µl of TE-buffer pH 8 or H2O.
STET-buffer:
8 g Sucrose
5 ml Triton-X-100
5 ml 1M Tris/Cl pH 8
10 ml 0.5M EDTA pH 8
80 ml H2O
TE-buffer: 
10 mM Tris/Cl
0.1 mM EDTA pH 8
Mini-preparation of plasmid DNA from E.coli using STET-buffer does not eliminate
traces of  RNA. If required RNA was removed by RNase treatment (20 µg/ml, 30 min, at
room temperature) followed by phenol precipitation of the protein and ethanol precipitation of
the DNA. DNA was re-suspended in 50-µl TE, pH 8.
Method with Qiagen-kit
Plasmid DNA purified by the QIAprep miniprep - procedure, was done as described
in the protocol of the Qiagen-kit. There is expected a purification of up to 20 µg of high-copy
plasmid DNA from 1-5 ml over night cultures of E.coli in LB-medium.
The QIAprep miniprep procedure is based on three steps: preparation and clearing of
a bacterial lysate, a selective adsorption of plasmid DNA onto silica-gel membrane in the
presence of high salt buffer, washing and elution of plasmid DNA in low-salt buffer. Elution
efficiency is dependent on pH. The maximum elution efficiency is achieved between pH 7.0
and 8.5.
The cell pellet from 2 ml liquid culture in LB-medium with ampicillin was completely
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re-suspended in buffer-P1 with RNaseA (250 µl). Buffer-P2 (250 µl) was added and the
sample was inverted gently. The lysis reaction was allowed to proceed for maxim 5 min when
buffer N3 (350 µl) was added and the tube was gently mixed.  The solution turned cloudy due
to buffer N3 containing high salt concentration. After 10 min centrifugation, a compact white
pellet containing co-precipitated chromosomal DANN with insoluble complexes containing
salt, detergent, and protein, was formed. The resulted supernatant containing the plasmid
DNA was applied to a QIAprep column, centrifuged for 30-60 sec, the flow-through was
discarded and the QIAprep spin column was washed with buffer PB (0.5 ml) and buffer PE
containing ethanol (0.75 ml). DNA was eluted with 50 µl of buffer EB (10mM Tris, pH 8.5)
or H2O and stored at –20°C.
3.3.3.       Transformation of E.coli cells
3.3.3.1. Transformation of E.coli by CaCl2 method
Preparation of E. coli cells competent for transformation
The use of bacteria as host cells in cloning experiments requires bacterial cells
competent for DNA uptake. Usually, competent bacterial cells were prepared either fresh or
in advance and stored as stock of 200 µl-aliquots at temperatures lower then –70°C.
For making competent cells by chemical method a pre-culture (0.4 ml) of E.coli in LB-
medium without ampicillin were used to inoculate LB-medium without ampicillin (40 ml). After
incubation at 37°C for about 1.5 h, time when bacteria grew exponentially (OD600 = 0.3), the
cells were harvested by centrifugation in a JA-20 rotor at 7500  rpm, for 10 min at 4°C.  The
cell pellet was re-suspended in pre-cooled 40 ml of 0.1 M CaCl2 for at least 45 min or over
night on ice. Afterwards, the cells were harvested as before and re-suspended in 2 ml of ice-
cold 0.1 M CaCl2.
Transformation of E.coli with plasmid DNA
E.coli was transformed by adding 25-250 ng of yeast plasmid DNA to 200µl sus-
pension of bacterial competent cells. After incubation for 30 min on ice, heat-shock at 42° C
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for 3 min and chilling on ice for 1-3 min, 1 ml of LB-medium without ampicillin was added.
After incubation for 1 hour at 37°C, the cells were harvested at 12000 rpm for 2 min and the
supernatant volume was reduced to 250 µl. The re-suspended cells were plated out as 50 µl
and 200 µl on different LB-plates with ampicillin (LB-Amp) for incubation (at 37 °C)
overnight. If a Blue/White selection was desired, the cells were plated out on LB-Amp plates
with 50 µl of 10% X-Gal - stock-solution in DMF and 50 µl of  100 mM (i.e. 23 mg/ml)
IPTG  in H2O.
3.3.3.2. Bacteria transformation by electroporation
Making bacteria competent cells for electroporation
An E. coli culture (50 ml) grown over night until OD600 = 0.35, was transferred
to a pre-chilled, sterile polypropylene tube and left on ice for 15–30 min prior centrifugation at
5000 rpm in JA-10 rotor for 15 min at 4°C.  The cell pellet was washed twice with sterile
water (50 ml, 25 ml) and once with 10% glycerol (20 ml). The cells were centrifuged at 6000
rpm in JA-20 rotor for 15 min at 4°C followed by re-suspending in 10% glycerol (2 ml) and
aliquoting. The cells were frozen immediately at –70°C.
Electroporation of plasmid DNA into E.coli
In pre-chilled Eppendorf – tube, plasmid DNA (10 ng, about 1.2 µl) was mixed
 gently with an aliquot of electrocompetent cells (40µl) and placed on ice for 10 min. The
mixture was transferred to a pre-chilled and sterile electroporation cuvette, which was further,
placed into the sample chamber of the electroporator (Stratagene, Model 1000). A pulse of
1800 V was applied. The cuvette was removed and immediately added into SOC-medium
(500 µl). The cell suspension was transferred to a sterile culture tube and incubated with
moderate shaking at 37 °C, for 30-60 min. Aliquots of the transformation culture were plated
on LB plates containing antibiotics.
SOC-medium
Yeast extract 0.5 g
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Bacto-tryptone 2 g
NaCl 60 mg
KCl 19 mg
MgSO4 x H2O 200 mg
3.4. Biochemical protocols
3.4.1. Determination of protein concentration
Quantification of the amount of proteins in a solution was accomplished using
colorimetric methods: the Bradford and the Lowry method.
3.4.1.1. Determination of protein concentration by Bradford method
The Bradford method (Bradford, 1976) depends on the quantitation of the
binding of a dye, Coomasie brilliant blue, to proteins and comparing this binding to that of
different amounts of a standard protein, usually BSA. The dye Coomasie Brilliant Blue G250
has the absorbation maximum at 465 nm. After binding the protein, the absorbance shifts to
595 nm.
For assay a standard protein solution (BSA) was prepared to the concentration of
1mg/ml (1mg of BSA was dissolved in 1ml H2O). Duplicate aliquots of 0, 5, 10, 15 and 20 µl
of the BSA-solutions as well as the protein solutions to be measured, were pipetted to
Eppendorf-cups. H2O was added to a final volume of 800 µl. To these, 200 µl of the dye-
solution were added. After vortexing, the cups were allowed to stand 5 min at room
temperature. Within 1 hours after mixing standard and samples were measured at 595 nm in
plastic cuvettes of 1 ml and with 1 cm path-length. Unknown protein concentration was
determined from the standard curve obtained by plotting absorbance at 595 nm versus protein
concentration of aliquots of BSA-solution. The range of the determination has to be of 1-20
µg per sample; if required dilutions of unknown protein solutions were done.
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3.4.1.2. Determination of protein concentration by Lowry method
The Lowry method depends on the colour obtained from the reaction of  Folin-
Ciocalteu phenol reagent with tyrosyl residues and comparing this value to the extinction values
derived from a standard curve of a standard protein, usually BSA.
Two solutions (A and B) were prepared as described. To 5-20 µl protein extract was
added H2O to final volume of 100µl. Then there was added 1 ml of solution A and incubated
10 min at room temperature. Afterwards, 100 µl of solution B were added and incubated 10
min at room temperature. The absorbance at 660 nm was measured.
5, 10 and 15 µl BSA stock solution (1mg/ml) was used. Unknown protein
concentration was determined from the standard curve obtained by plotting absorbance at 660
nm versus protein concentration of BSA-samples.
Solution A:
100 vol. 3% Na2CO3 in 0.1N NaOH
    1 vol. 4% NaK-Tartrat
    1 vol. 2% CuSO4.5 H2O (add drop by drop, under stirring!)
Solution B:
    1 vol. Folin-reagent
    2 vol. H2O
3.4.2.       Precipitation of proteins
3.4.2.1. Methanol precipitation
To 1 volume of protein solution, 2 volumes of methanol and 2/3 volume of chloroform
were added. After a centrifugation at 12000 rpm, for 2 min, the upper phase was discarded.
1ml methanol was added to the tube and mixed again. A new centrifugation at 12000 rpm for
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2 min, was performed and the supernatant was completely discarded. The protein pellet was
re-suspended in sample buffer or stored at –20°C.
3.4.2.2.   TCA precipitation
To one volume of protein solution TCA yielding to final concentration of 10% was
added and mixed. After 30 min on ice, the samples were centrifuged for 10 min at 13000 rpm.
The resulted pellet was washed with 4°C - cold acetone, dried in a speed vacuum (model
Speed Vac SVC 100H from Savant Instruments) and re-suspended in sample buffer.
Alternatively, protein was precipitated by 20% TCA 80% acetone.
3.4.3. SDS -polyacrylamide gel electrophoresis
One-dimensional gel electrophoresis of the proteins can provide information about the
molecular size and purity of proteins, as well as the number and molecular size of subunits.
3.4.3.1. Sample preparation
The proteins loaded on SDS-PAGE were either protein solutions, or protein pellets.
Sample preparation is required prior loading proteins on SDS-PAGE.
The sample preparation was performed differentially: either protein solution was
diluted 1:1 with 2x protein solubilizer, or the protein pellet was re-suspended in 1x protein
solubilizer buffer. The protein solubilizer contained SDS as a denaturing reagent and ß-ME or
DTT to reduce disulphide bonds. To bring proteins in solution, vortexing of 1-2 min per
sample was usually enough and exceptionally sonication was performed. The probes were
boiled for 5-10 min at 95 °C. A centrifugation step at 13000 rpm in a table top-centrifuge at
room temperature for 3-5 min was performed and the supernatant was loaded in the pockets
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of stacking gel. The protein-molecular weight standard was diluted in 1x SDS protein
solubilizer buffer according to supplier’s instructions and used as molecular mass marker.
Two protein solubilizer buffers were used (type A and type B). Usually, protein
solubilizer-buffer-type A was used for solubilization of the proteins pellet form resulted from
methanol precipitation and protein solubilizer-buffer-type B was used for solubilization of the
proteins in pellet form resulted from TCA precipitation and for dilution of the protein in
solution.
1x  Protein Solubilizer Buffer - type A
100 mM Tris/HCl pH 6.8
 0.1 %          Bromphenolblue (BFB)
 15 %     Sucrose
 10 %     SDS
 10 mM        DTT
Three stock solutions were prepared: solution 1, 2x (200 mM Tris/HCl pH 6.8, 0.2%
BFB, 30% Sucrose; store at –20°C), solution 2, 2x (20% SDS) and solution 3, 100x (1M
DTT). A working solution 1x was obtaining by mixing 1:1 solution 1 with solution 2; solution 3
was added always fresh to final concentrations.
2x Protein Solubilizer Buffer - type B
20 mM DTT or ß-ME
2 % SDS
250 mM Tris/HCl, pH 6.8
20 % Glycerine
To prepare 1 ml of 2x Protein Solubilizer - type B, 3.1 mg DTT and 20 mg SDS were
dissolved in ddH2O to 0.3 ml. To this 0.5 ml of 0.5 M Tris /HCl pH 6.8 and 0.2 ml Glycerine
were added. Just before use, 20 µl of 1M DTT were added to 980 ml of 2x Protein
Solubilizer Buffer-type B without DTT.
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3.4.3.2. Laemmli gel system: denaturing discontinuous gel electrophoresis
By one-dimensional gel electrophoresis under denaturing conditions (0.1% SDS)
proteins are separated according to their molecular mass. Proteins migrate toward the anode
through pores in the polyacrylamide gel matrix. The pore size decreases with higher acrylamide
concentrations.
The polyacrylamide gel was casted as a separating gel topped by a stacking gel and
secured in a vertical electrophoresis apparatus, under temperature control.
The stacking gel allows the concentration of the proteins before entry in the separation
gel. Lengths of 11-12 cm size of 1mm thickness and 10% concentration of the separation gels
were sufficient for separation of proteins up to 100 MW with a good resolution.
To make a separating gel, the glass-plates were cleaned with H2O and detergent,
rinsed with technical ethanol (or methanol) and assembled as a sandwich which then was
locked in the casting stand. Separating gel solution (as described in the table 11), were
prepared and poured between the glass plates. Above it 1 ml butanol (H2O saturated) was
added to achieve a uniform polymerisation of the gel. After polymerisation of the separating
gel, the 2-butanol was removed, rinsed twice with H2O, and the stacking gel prepared as
described in table 12 and poured on top of the separating gel. Immediately after the gel was
poured, a comb of required size and teeth-number was introduced to make the pockets for
sample application.
Tables 11: Recipes for polyacrylamide separating gels
CONCENTRATION
SEPARATING GEL
5% 7.5% 10% 12.5%
30%   Acrylamide, 0.8% Bisacrylamide 5.25 ml 7.9 ml 10.5 ml 13.1 ml
1,5 M Tris/HCl pH 8.8, 0.4%  SDS (w/v) 7.5 ml
10%    APS 250 µl
TEMED 25µl
H2O 16.98 ml 14.33 ml 11.73 ml 9.12 ml
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Tables 12: Recipe for stacking gel
CONCENTRATIONSTACKING GEL
4%
30% Acrylamide, 0.8% Bisacrylamide 1.3 ml
0.5M Tris/HCl pH 6.8, 0.4%  SDS (w/v) 2.5 ml
10%    APS 100 µl
TEMED 10 µl
H2O 6.1 µl
1,5 M Tris/HCl pH 8.8, 0.4%  SDS (w/v)
91g Tris-base were dissolved in 300 ml H2O. The pH was corrected to 8.8 with 1N
HCl and the volume was completed with H2O till 500 ml. 2 g SDS were added at the end.
The solution was stored at 4°C.
0.5 M Tris/HCl pH 6.8, 0.4%  SDS (w/v)
6.05 g Tris-base were dissolved in 40 ml H2O. The pH was corrected to 6.8 with 1N
HCl and the volume was completed with H2O till 100 ml. 0.4 g SDS were added at the end.
The solution was stored at 4°C.
The proteins were run in an anode – cathode buffers containing system. The SDS-
PAGE separations were performed under constant current at 50 mA 4°C for about three
hours. A SDS-Electrophorese System (model SE-600 from Hoeffer Scientific Instr.) and the
electrophoresis power supply (model 494, ISCO) were used
Anode Buffer for SDS-PAGE (pH=6.8):
50 mM Tris/HCl
192 mM Glycine
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Cathode Buffer for SDS-PAGE:
1% SDS (w/v)
0.001% Bromphenolblue
in Anode Buffer
3.4.4. Staining proteins in gel
Two methods were used to detect the location of the proteins in gels: Coomasie blue
staining and Silver staining.
3.4.4.1. Coomasie blue staining
The detection limit by Coomasie Blue staining is of 0.3 - 1 µg per protein band and
depends on non-specific binding of the dye, Coomasie Brilliant Blue, to proteins.
Coomasie Blue Staining and distaining of the proteins were performed using a “direct
colloidal Coomasie-Staining“ (Wiltfang et al., 1991). Stained gels were dried between
celophan-folia in gel dryer type G1200 (Fröbel)
Hydrated gels were stained for about 12 hours, in a colloidal suspension of  0.1%
(w/v) Coomasie brilliant blue G 250 in 10% (w/v) (NH4)2SO4, 2% (v/v) H3PO4 and 20%
(v/v) CH3OH.
A working colloidal suspension was made by adding 20 ml CH3OH to 80 ml of stock
colloidal suspension. The stock colloidal suspension was prepared by dissolving, in that order,
in about 800 ml H2O, 100 g (NH4)2SO4 and 20 g 85% H3PO4. The volume was corrected to
980 ml with H2O. At the end, 20 ml of 5% solution Coomasie Brilliant Blue (in 10%
CH3COOH, 50% CH3OH) were added under stirring.
To remove the dye-particles attached to the surface,  gels were rinsed twice with 25%
(v/v) CH3OH.
3. MATERIALS AND METHODS
______________________________________________________________________
44
3.4.4.2. Silver staining
Detection of protein bands in a gel by silver staining depends on binding
of silver to various chemical groups (e.g. sulfhydryl and carboxyl moieties) in proteins. The
detection limit is 2 to 5 ng per protein band.
To obtain Silver staining gels were fixed in two solutions: first, for 1-12 h, at 4°C, with
30% Ethanol, 10% Acetic acid, and second, for 1 h, with 30% Ethanol, 0.5M NaAcetat
0.5% Glutaraldehyde 20 mM Na2S2O3. After three washing steps with cold H2O for 15 min
each, the gels were stained with silver nitrate solution for 1 h, then developed for 3-10 min,
with developing solution and stopped (30 min) with 0.05 M Glycine.
Silvernitrate solution for staining
0.1 g AgNO3 was dissolved in 80 ml H2O. 54 µl of 37% Formaldehyde was added
and the final volume was completed with H2O to 100 ml.
Solution for developing
2.5 g Na2CO3 was dissolved in 100 ml H2O. 54 µl of 37% Formaldehyde was added
just before use.
3.4.5. Western blotting
3.4.5.1. Protein transfer with Semi-Dry systems
Following separation by SDS-PAGE, the proteins (antigens) were transferred to
a support - membrane (nitro-cellulose or PVDF membrane) in a semi-dry blot system. The
assembly of immunoblot sandwich is shown on the figure 6.
Before building up the immunoblot sandwich, the gel, chromatographic paper sheets
(type Schleicher & Schüll, GB002) and the nitro-cellulose membrane  (Sartorius, BA 85, 045
µm) were cut to the exact size. Then, the nitro-cellulose membrane was soaked in H2O.
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Similar, 4 sheets of blotting paper each were soaked in anode-buffer and in cathode-buffer,
respectively. The anode buffer - sheets were placed one by one on the bottom of the stack
followed by nitro-cellulose membrane and then the gel. The cathode buffer - papers were
applied without air bubbles, and excess liquid was wiped off.  The upper part (cathode) of the
apparatus was placed on the stack and a weight of approximately 750g was put on top. A
constant current of 1mA/cm2 was applied for protein transfer for 60-80 min.
If a PVDF membrane was used in state of nitro-cellulose an activation of the
membrane was required. This was done as follows: the membrane was let floating on the
surface of methanol, rinse for 5 min in distilled H2O and immerse in transfer buffer (cathode
buffer) for 10min. PVDF-membrane must be kept wet at all times.
Figure 6: Scheme of Semi-dry blot sandwich
  The arrow shows the electro-transfer direction of the proteins.
Cathode buffer for Western-Blot Semidry, pH 9:
40 mM e-Amino-n-caproic 10.5 g
20 mM Tris/Cl 4.85 g
20% Methanol 400 ml
H2O till 2 l
3-4x filter paper
transfer membrane
3-4x filter paper
weight (0.75 kg)
+
Anode
Cathode
-
gel
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Anode - buffer for Western-Blot Semidry, pH 7.4:
75 mM Tris/Cl 18.2 g
20% Methanol 400 ml
H2O till 2 l
3.4.5.2. Protein detection on membranes
3.4.5.2.1. Ponceau staining
The transfer of proteins from a SDS - polyacrylamide gel was monitored either by
staining the gels after blotting (see above) or on blot transfer membranes with Ponceau S
solution.
Following protein transfer to nitro-cellulose or PVDF, the membrane was placed in
Ponceau S solution 5 min at room temperature. For de-staining, the membrane was placed in
H2O till the background became white (2-10 min).
3.4.5.2.2. Antibody detection
Immobilised proteins are probed with specific antibodies to identify and quantitate
antigens present.
The membrane is immersed in a blocking buffer to cover all protein-binding sites with
a non-reactive protein or detergent. Blocking buffer was TBS-Tween 20 (1x) with 5% milk
powder. The incubation was done on a shaker, either o/n, at 4°C, or for 1 h 30 min, at 37°C.
The membrane is placed in a solution containing the antibody directed against the antigen
(primary antibody). For this purpose, the membranes were incubated in TBS-Tween 20(1x)
with 5% milk powder in the presence an appropriate dilution of antibodies, as described in the
table no. 3-1. For best results as well as because the need of reusing the same buffer with
antibody against Aminopeptidase 1, the incubation was performed over night at 4°C. The
optimum was obtained for a dilution of 1:1000. All other antibodies were used at optimum
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dilution for minimum 1h 30 min at room temperature. If necessary the incubation was
performed also o/n at 4°C. To remove the non-specific binding two washing steps with TBS-
Tween 20 (1x), for 10 min were done before the blot was exposed to an enzyme-antibody
conjugate directed against the primary antibody. For immunoprobing with directly conjugated
secondary antibody, the membranes were incubated with goat/anti-rabbit IgG coupled
horseradish peroxidase (HRP) as second antibody in TBS-Tween 20(1x) with 5% milk
powder, dilution 1:10000. Complexes protein–antibody were visualised by treatment with
developing reagent after 3 washing steps of 2x 10 min 1x 5 min with TBS-Tween 20 (1x).
TBS-Tween-20 (1x):
10 mM Tris/Cl pH7.4
150 mM NaCl
0.1% Tween 20
To prepare 10x concentrated TBS - Tween 20 1.21 g Tris-base and 8.77 g NaCl in
were dissolved 80 ml bdH2O. The pH was corrected to 7.4 with HCl. 1 ml Tween 20 and
bdH2O were added yielding a final volume of 100 ml. A working solution was obtained by
diluting 1:10 this solution in H2O.
3.4.5.2.3. Visualisation with luminescent substrates
Two methods were used for visualisation of the proteins on the blotting membrane:
Pierce-kit and luminol / p-coumaric acid system. Both methods are based on using
chemiluminescent substrates.
Chemiluminesce is a chemical reaction that results in light emission. The chemical
reaction that occurs between horseradish peroxidase (HRP) and luminol in the presence of
hydrogen peroxide produces a weak light. With the addition of an enhancer, the light that is
produced intensifies and the light emission duration increases. The maximum light emission
wavelength is 425 nm and the initial flash of light occurs instantaneously after the reaction of
the substrate with the enzyme.
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Visualisation with luminol / p-coumaric acid system
When using luminol / p-coumaric acid system: after the final wash, the blot was
immersed in a freshly prepared substrate solution for 1 min. There is no need to do this in the
dark; the chemiluminiscence is quite stable in daylight. The excess of liquid was drained from
the blot by pressing it between two filter papers. It was very important to drain the blot
properly; the system is so sensitive that all extra liquid will result in background! The blot was
wrapped in cellophane and exposed.
Substrate solutions:
Solution 1(10 ml): 100 µl 250 mM luminol
                44 µl 90 mM p-coumaric acid
       1 ml 1M Tris-HCl pH 8.5
                     8.85 ml H2O
Solution 2(10ml):     6 µl H2O2, 30%
        1 ml  1M Tris-HCl pH 8.5
        9 ml H2O
Luminol
0.44 g into 10ml DMSO, aliquot into 100 µl portions for single use. Store –20°C.
p-coumaric acid
0.15 g into 10 ml DMSO, aliquot into 44 µl portions for single use. Store –20°C.
Visualisation with Pierce-kit
Another possibility of visualising the imunocomplexes was the incubation of the blot
membrane in a working solution of SuperSignal Substrate that is available commercially.  A
Pierce-kit, named SuperSignal Substrate, Western Blotting, contains two solutions,
Luminol/Enhancer Solution and Stable Peroxide Solution. These must be stored at 4°C.
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To prepare a working solution, equal parts of Luminol/Enhancer Solution and Stable
Peroxide Solution must be mixed prior use. Recommended volume is 0.125 ml/cm2 of blot
surface. The incubation time is of 5-10 min and there is no need to prepare the solution in
dark. To reduce background, the excess of liquid from the blot must be drained out.
Afterwards, the blot is wrapped in cellophane and exposed.
The exposure was done in a dark room either to X-ray films or using a CSC camera,
depending on the time required for exposure. Usually, for up to 5 min exposure time a CSC
camera was used. For longer exposures (like 15 min to overnight), the choice was X-ray films.
A film cassette insured a tight fit between membrane and film.
3.4.5.2.4. Protein size determination
Protein size determination using prestained markers
For SDS-PAGE and Western blot analysis, prestained markers for high molecular
weight range have been used: RainbowTM coloured protein molecular weight markers (from
Ammersham Life), Prestained protein molecular weight markers (Calbiochem), BenchMarkTM
prestained protein ladder (from Gibco BRL).
Prestained markers are mixtures of pure proteins of known molecular weight. They are
loaded into SDS-PAGE and further transferred to the blot membrane as is done with the
protein samples. The stain makes them visible during electrophoresis and therefore their
movement can be monitored even after the marker dye front has migrated off the gel, aiding in
optimal resolution of high molecular weight polypeptides. After immunoblotting prestained
markers give information about the transfer of the proteins. Because the covalently coupled
stain causes a slight change in electrophoretic mobility, prestained protein molecular weight
markers provide only approximate size information.
Protein size determination using purified proteins of high molecular weight
Finding the molecular weight of proteins of higher molecular weight then 200 was
solved by performed glycerol gradients. Proteins of known molecular weight, like
ovalalbumine (43 kDa), BSA (68 kDa), tyroglobuline (669 kDa), were separated on step
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glycerol gradients, collect a number of equal fractions and load on SDS-PAGE. The gels were
stained with coomasie staining and identified the fraction corresponding to a certain molecular
weight. Standard curves were obtained by plotting log MW versus fraction number where
protein has been found abundant. The molecular weight of unknown proteins, separed under
the same conditions but transferred to membrane and visualised using methods described, was
determined based on the abundance on the fractions, from the standard curve.
3.4.5.3. Stripping and reusing western – blot membranes
Two methods of striping off the immuno-detection systems were used.
Stripping with NaOH consists in three incubation steps: first, in H2O for 5 min,
then in  0.2N NaOH for 5 to 30 min, and last, for 5-10 min in H2O.
Stripping with stripping buffer: the blot was incubated with a stripping buffer (2% w/v
SDS, 62.5 mM Tris-HCl pH 6.8, 100 mM b  mercaptoethanol) for 30 min at 50-70°C and
washed with washing buffer (TBS-Tween 1x) 2 times (10 min each).
Re-probing membranes after stripping was done beginning with blocking reagent as
described in western blot procedures.
3.4.6. Preparation of yeast cell extracts
The procedure of preparing yeast cell extract for SDS-PAGE consists in preparing
spheroblasts, and then destroying their surrounding membrane by mechanic treatment and
temperature shock.
For this purpose exponentially or stationary growing cultures, cultivated at 30°C in
YPD or MV-media were used. Spheroblasts were prepared from a starting amount of cells
equivalent to 20 OD600.
Cells were harvested at 3000 rpm, for 5 min, in a Heraeus – centrifuge and the
supernatant was discarded. The cell-pellet was re-suspend in 1ml/10 OD600 in 0.1M Tris/SO4
pH 9.4, 10mM DTT (freshly added) and incubated over 20 min at 30°C.  Afterwards, the
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cells were spun down at 1500 rpm for 5 min in Heraeus – centrifuge, the supernatant was
discarded and the cell-pellet re-suspended in 2ml/10 OD600 of 1.2 M Sorbitol, 50 mM Tris/Cl
pH 7.5, 10 mM EDTA. For lysis of the cell wall, lyticase (2.5 µl /10 OD600  cells; i.e. 0.125
µg per OD600  cells) was added and incubated with shaking for 30 min, at 30°C. Spheroblast
formation was monitored at 600 nm after hypo-osmotic shock of the cells. Spheroblasts were
spun down at 1500 rpm for 5 min in Heraeus – centrifuge and re-suspended in 700 µl of
0.1M NaPi pH 7.4 with inhibitors (70 µl NaN3 10%, 3.5 µl 0.2M PMSF, 0.7 µl 5-inhibitor
mix). From now on the extract must be kept on ice.
Spheroblasts, transferred in a new Epp-cup containing 300 µl cold glass beads and
were broken by vigorously mixing (vortex) for three times each 2 min followed by cooling for
at least 1 min on ice. Glass – beads, unbroken cells and nuclei were spun down at 500g. The
supernatant was transfer into a new Epp-cup and protein concentration was determined.
Proteins were stored at –20°C.
3.4.7. Determination of enzymatic activities
3.4.7.1. Specific enzymatic activitiy
The specific activity of Ape1p and CPY were measured in cell extracts prepared
similar as for western blot analysis. Two modifications of the original protocol were
introduced: first, the extract was prepared free of protease inhibitors and second, it represents
the supernatant fraction from an extra centrifugation step (5 min, 13000 rpm, in tabletop
centrifuge).
Protease assays were based on discontinuous spectrophotometric recording, in
thermoregulated cuvettes, at 405 nm. The measurements began immediately adding the
enzyme solution to reaction mixture containing substrate, buffer and H2O. Due to the instability
of the substrate, an unspecific activity was measured. Velocity of reaction was calculated from
the rate of change of absorbance with respect to time, using the difference between molar
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absorptivity of the substrate and reaction product. Specific activity was expressed in mU x
(mg)-1.
Formula for calculation of specific activity
mU x (ml)-1 = (DE x 1000 x Vt) x (Vs x e x Dt)-1
mU x (mg)-1 = mU x (ml)-1 x mg (ml)-1
3.4.7.1.1. Ape1p-activity assay
The mApe1p - activity was measured by incubating protein extract with H-Leu-pNA,
as a substrate, at 30°C. ZnCl2 (cf = 1 mM) was added as activator of Ape1p. The
absorbance at 405 nm was measured at different time points: 0, 15, 30 and 45 min. The
extinction coefficient (e) of free pNA at 405 nm is 10.5 M x (cm)-1.
Ape1p- assay-mixture (1.5 ml):
900 µl buffer (75 mM Tris/Cl pH 7.5, 3 mM EDTA)
100 µl 10 mM ZnCl2 in buffer
75 µl 20 mM H-Leu-pNA (i.e. 5.27 mg/ml in DMSO)
20 µl protein extract (or NaPi pH 7.4, for control)
405 µl H2O
3.4.7.1.2. CPY-activity assay
The measurement of CPY-activity was done by incubating protein solution with
substrate mixture at 25°C. Prior reaction, protein solution was prepared by treating protein
extract with EDTA (cf  = 5 mM) and SDS (cf = 0.25%) and incubation at 25°C, for 10 min.
The absorbance at 405 nm was measured immediately after mixing (point zero) and at
different other time points: 0, 15, 30 and 45 min. The extinction coefficient of the oxidation
product of o-dianisidine at 405 nm is 7.25 M x (cm)-1.
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CPY- assay-mixture (1.1 ml):
500 µl solution 1
500 µl solution 3
  50 µl solution 2
   50 µl Protein extract (or NaPi, for control)
Solution 1 (in 0.1 M NaPi  pH 7.4):
0.25 mg/ml L-amino acid oxidase
0.40 mg/ml Horseradish Peroxidase
Solution 2 (in H2O):
2 mg/ml o-Dianisidine
Solution 3 (in 0.1 M NaPi pH 7.4):
20 mM Z-Gly-Leu (i.e. 6.4 mg/ml)
3.4.7.2. Ape1p activity of yeast colonies
Ape1p activity of yeast colonies was determined by an Ape1p -‘overlay’ assay.
 is based on enzymatic activity of the mature amino-
peptidase 1 (mApe1p). To test for presence of mApe1p in vivo, an overlay agar, containing
leucine-ß-naphthyl-amide (H-Leu-b-NA) as substrate, was prepared. Chloroform
permeabilizes cells on the surface of colonies. Aminopeptidase 1 catalyses cleavage of H-Leu-
b-NA and ß-naphthylamide (ß-NA) is released. Due to the product fluorogenic group, a
strong fluorescence if illuminated at 365nm is observed. Caution: ß-naphthylamide is a
carcinogen.
Ape1p -‘overlay’ was performed with fresh cells, as single – colony streaks, grown on
selective media-plates (MV-plates). Chromatographic-paper-filters (Ø 80 mm, Schleicher and
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Schuell) were labelled with a pencil, transferred onto the MV-plates and let stand until the
entire filter turned wet. The replica – filters were taken off from the plates, transferred onto
YPD-plates with the colony-site up and incubated over night. The filters were taken from the
plates and placed with the colony-site down into CHCl3 for 20-30 sec. Excess of CHCl3 was
sucked off and the filters were dried on paper-sheets. The filters were placed in Petri dishes
and covered with assay-agar.
The assay-agar mixture was prepared by mixing the buffer and the melted agarose in a
Falcon tube thoroughly. The substrate-solution (always prepared fresh!) was added and
vortexed. Immediately, per one plate, 5 ml of agar solution was poured over the colonies.
Plates were incubated at room temperature for 15-30 min. Then, the activity of Ape1p was
detected with an UV-lamp of 365nm.
Assay-agar mixture:
For 1 sample (Vf  5 ml):
50 mM Tris/Cl pH 7.5 3.33 ml   75mM Tris/Cl pH 7.5 3mM EDTA
2 mM EDTA
0.6 % agarose 1.42 ml   2% agarose
10 mM H-Leu-b-NA 0.25 ml   200 mM H-Leu-b-NA in CH3OH
3.4.8. Protease protection experiments
3.4.8.1. Protease protection assay
Protease protection assays were performed using 70 OD cells, grown to OD600  0.7-
1.1. Cell extract containing intact vesicles and vacuoles was prepared similar as for western
blot analysis until spheroblasts were obtained. Maximum efficiency of spheroblast formation
was obtained with 0.2 mg/50 OD600 cells zymolyase 20 T, in 1ml/6 OD600 cells of 0.6 M
Sorbitol, 50 mM KPi pH 7.5, 10 mM DTT, 0.2% Glucose in YP-medium. Incubation was
done for 15 min, at 30°C, with shaking at 200rpm and 15 min, at 30°C, standing but mixed
gently each 5 min.
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Further, spheroblasts were carefully lysed (by differentially lysis) leaving intact
subcellular vesicles. To check for intact vesicles, lysed material was centrifuged (15 min at
8000 rpm, 4°C in Eppendorf-centrifuge). Pellet and supernatant were analysed in western blot
with specific markers (carboxypeptidase Y (CPY) – vacuolar, a-Hexokinase (a-HK) -
cytosol). Pellet should contain intact vesicles and supernatant should contain cytosol and
eventually the contents of broken vesicles.
Differential lysis of the spheroblasts suspension in SP – buffer (Vf  = 720 µl / 50 OD
cells) was done by adding DEAE-Dextran (Vf  = 45µg / 50 OD cells) and incubating
successively for 1 min at 4 °C, non-shaking; 5 min at 30°C, shaking (70 rpm); kept at 4 °C
after incubation.
SP – buffer:
200 mM Sorbitol, 20 mM Pipes pH 6.8
Protease protection was tested as follows: lysed material is incubated at 4°C for 30
min without adding protease, in presence of tyrosine or proteinase K (each 50 µg/ml) and in
presence of either protease and 0.2% Triton X-100. Incubation is terminated by adding
PMSF to cf = 1 mM and incubation for 10 min at 4°C, and afterwards adding 1 volume 20%
TCA 80% acetone. Processing of pApe1p can be analysed after SDS-PAGE by western –
blotting.
Subfractionation of lysed spheroblasts was performed by ultracentrifugation,
using  a TLA100.3 rotor, at 100000g for 45 min 4°C.
 In total lyzed spheroblasts (corresponding to 70 OD cells) were used for
subfractionation and protease protection experiment of the subfractions. The spheroblasts
were subjected to differential lysis, using 60-90 µg DEAE-Dextran/100 OD cells. From cell
homogenate,  a part (corresponding to 10 OD cells) was centrifugated on 100 µl 10% ficoll
(in order to avoid breaking the vesicles during ultracentifugation) after mixing with 0.72 µl
stock solution PMSF (in order to avoid unspecific processing during procedure). Three
fractions are collected: pellet (P), ficoll (F) and supernatant (S) and analysed in western blot.
Another part of lyzed spheroblasts (corresponding to 60 OD cells) was mixed with 300 µl
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10% ficoll and centrifugated. Ficoll (350 µl) and supernatant (700 µl) fractions are subjected
to protease protection assay, as described.
3.4.9. Glycerol gradient fractionation
Glycerol gradient centrifugation was performed to analyse homo-oligomerization.
Yeast crude extract used for Glycerol Gradients was prepared as described for western blot
analysis, from 40 OD cells in logarithmic or stationary growth phase. To reduce volume,
spheroblasts pellet was re-suspended in 700 µl of 0.1 mM NaPi pH 7.4 plus protease
inhibitors, as follows: 70 µl NaN3 10%, 7 µl PMSF, 1.4 µl 1000x 5-inhibitor mix. The extract
was used fresh.
Calibration of the glycerol gradient was done with known proteins: thyroglobuline
(MW 669), BSA (MW 65), ovalalbumine (MW 45). Due to their molecular weight they
migrate in different fractions of the gradient.
Glycerol gradients preparation
Preparation of step - glycerol gradients was done using 20% – 50% of glycerol in 20
mM K-PIPES pH 6.8 (1x).
Table 13: Recipe of preparing solution (40%, 30% and 20%) for glycerol gradient
STOCK SOLUTION 20% 30% 40%
Glycerol 50% 1760µl 2640µl 3520µl
K-Pipes 1x 2640µl 1760µl 880µl
Vf 4400µl 4400µl 4400µl
Setting Glycerol Gradients
The Glycerol Gradient tube has to be filled up completely, in order from the bottom to
the top, with:
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Glycerol 50% 525 µl
Glycerol 40% 525 µl
Glycerol 30% 525 µl
Glycerol 20% 525 µl
Protein extract (1.2-1.5 mg)      400 µl
Vf 2500 µl
The gradients without protein extract could be prepared in advance and stored at -80°C.
Centrifugation of the Glycerol Gradients
Centrifugation of the Glycerol Gradients was done in a tabletop ultracentrifuge with a
rotor TLS-55 at 55000 rpm, at 15 °C, for 4 h.
Collection of the fractions and preparation of the samples for SDS-PAGE
After separation by centrifugation, 10 fractions, of 250 µl each were collected
and TCA-precipitated as described. After 2-5x washings with cold acetone (4 °C), the
protein pellet was re-suspended in 80 µl sample buffer + DTT (1x). Samples were run in 10%
SDS-PAGE. As a control, 70 µg of the same yeast crude extract, solubilised in 70-90 µl
sample buffer + DTT (1x) was run on the gel.
3.4.10.  Isolation of pApe1p - containing vesicles in OptiPrep gradients
Isolation of pApe1p - containing vesicles was done in OptiPrep Gradients. 250 OD
fresh cell culture with OD600 start 0.9-1.1 was used.
Spheroblasting protocol was used with modifications, as follows. With the exception
of the incubation steps all other steps were carried out at 4°C. Cells were re-suspended in
spheroblasting buffer (1.2M Sorbitol, 50 mM Tris/Cl pH 7.5), 1ml/60 OD. Spheroblasts were
obtained using Zymolyase 20 T to cf = 0.5 mg/50 OD. Spheroblasts are collected by 6 min
centrifugation (2000 rpm, 4°C) in JA-20, and were lysed with 4 ml H2O, on ice for 5 min.
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Homogenate was separated from non-lysed spheroblasts by centrifugation at 2500 rpm 4°C,
two times 2 and 3 min, respectively.
From the protein extract, an aliquot was saved for TCA precipitation, as a con-
trol of crude extract. 2 ml crude extract were mixed carefully (use 1ml-cut tips and shaker
4°C) with 3 ml of 60% OptiPrep solution (the final concentration was 37%).
Set of OptiPrep gradients
Flotation gradients were set as follows:
5 ml 37% OptiPrep in protein extract,
2 ml 30% OptiPrep in 10 mM Pipes pH 6.8
2ml 25% OptiPrep in 10 mM Pipes pH 6.8
2ml 19% OptiPrep in 10 mM Pipes pH 6.8.
1.5-2 ml 10 mM Pipes pH 6.8
Centrifugation is done at 25000 rpm, for 6 hours, 4°C in L8-M Ultracentrifuge/
Beckman, with SW-40 ultracentrifuge rotor.
Collection and analysis of the fractions for OptiPrep Gradients
The 0% fraction, 0-19% interface, 19-25% interface, 25-30% interface, 30-37%
interface, 37% fraction were collected and TCA precipitated. Western blot analysis was done
with Ape1p, CPY and a-HK antibodies.
3.5. Manipulation of nucleic acids
3.5.1. Quantification of nucleic acids
The concentration of nucleic acids may be determined spectrophotometrically or by
comparison with a control sample of known concentration in an agarose gel. DNA can not be
distinguished from RNA by spectrophotometry since both exhibit a maximum absorbance at a
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wavelength of 260 nm. One OD unit corresponds to 40 µg/ml of RNA and one OD unit
corresponds to 50 µg/ml of double stranded DNA. It is recommended to use a dilution of the
RNA/DNA sample that will give an OD value between 0.1-0.5. Contamination of nucleic
acids with proteins is demonstrated by measuring the OD at 280 nm, since proteins typically
have a maximum absorbance at this wavelength. A 260/280 absorbance ratio of 1.8-2.0 is
appropriate for pure RNA/DNA. Contaminating protein will result in lower values of the
260/280 ratio.
3.5.2.  DNA manipulation
3.5.2.1. Electrophoresis of DNA in agarose gel
Medium- and large - size DNA molecules were separated on agarose gels using an
horizontal electrophoresis apparatus. Depending on the fragment-size, the concentration of
agarose-varied from 0.5% to 1.5% (w/v) (table 14). The necessary amount of agarose was
brought in 1 x TAE, boiled in microwave, cooled to approximately 55°C prior adding ethidium
bromide (cf = 0,5 µg/ml) and poured into the mould and a well-forming comb was immediately
positioned. After completely setting (at RT, for 15-30 min), the comb was removed and the
gel placed in the electrophoresis apparatus containing buffer (1 x TAE) sufficient to cover (1-3
mm) the gel. DNA-probes containing 1% (v/v) sample buffer (LP IV or Ficoll-Marker) were
Table 14: Agarose concentration required to separate nucleic acids of various sizes
   (according to Andrews, 1991)
AGAROSE (%) LINEAR NUCLEIC ACID SIZE
(KB)
0.5
0.8
1.0
1.2
1.5
0.7-45
0.4-20
0.3-10
0.2- 8
0.2 -6
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loaded in the wells of  the gel and run (3-4 V/cm) at RT. To determine the sizes of nucleic acid
molecules, a standard (DNA-ladder, 10µg per lane) was added.
Due to ethidium bromide (intercalating dye, binds to double-stranded DNA or RNA)
added to the buffer used for making up the gel, the progress of DNA separation was followed
at any stage by illuminating the gel with UV radiation. For this purpose a UV-Hand lamp (312
nm) or a transluminator (300nm) were used.
DNA - sample buffer:
LP IV: 0.25% Bromphenolblue
40% Saccharose in 1x TAE
Ficoll-Marker: 0.05% Bromphenolblue
0.05% Xylencyanol
15% Ficoll
DNA - standard (“DNA-ladder”): a mixture of oligonucleodides that comprise fragments of
defined size (75 kb – 12.216 kb).
3.5.2.2. DNA modifications
3.5.2.2.1. Digestion of DNA with restriction endonucleases
The activity of restriction endonucleases is declared in units (U). One unit of restriction
endonuclease activity is defined as the amount of enzyme required to completely digest 1 µg of
substrate DNA in a total reaction volume of 50 µl in one hour using the NEBuffer.
Restriction enzyme digestions were performed by adding the reagents into capped
microcentrifuge tubes and mixed gently with the pipette tip. Incubations were performed at the
appropriate incubation temperature (37°C or 25°C) as indicated on the technical data card,
for the desired length of time (1.5 - 3 hours). For analysis of reaction efficiency, an aliquot was
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subjected to agarose gel - electrophoresis. Whenever desired quantitative digestion, this was
performed under the same conditions but doubling the incubation time.
Reaction mixture for DNA – digestion (20-100 µl):
DNA
2x U restriction endonuclease
10% (v/v) reaction buffer 10 x
till Vf H2O
As reaction buffer was used the New England Biolabs (NEB) buffer system. These
buffers were provided from the manufacturer (as 10 x concentrated) together with the
enzymes. The NEB system consists beside enzyme-specific buffer of four basis-buffers, as
follows (given final concentration):
NEB 1:50 mM Tris/HCl (pH 7), 10 mM MgCl2, 1 mM DTT
NEB 2:50 mM Tris/HCl (pH 8), 10 mM MgCl2, 1 mM DTT, 50 mM NaCl
NEB 3:50 mM Tris/HCl (pH 8), 10 mM MgCl2, 1 mM DTT, 100 mM NaCl
NEB 4:50 mM Tris/HCl (pH 8), 10 mM MgCl2, 1 mM DTT, 50 mM KOAc
3.5.2.2.2. Preparation of plasmid-vectors for subcloning DNA - fragments
Plasmids were used as cloning vectors. They were digested at one locus either by
a single restriction enzyme or by two at a multi-cloning site to achieve insertion of target DNA
in a defined orientation. Digestion products were separated on agarose gel electrophoresis and
DNA recovered using Qiagen – kit for DNA – gel extraction.
Whenever desired, the digested vector was treated with alkaline phosphatase for
removing the 5’-phosphates from the digested plasmids. The aim was prevention from self
ligation of the vector and therefore reducing the background of colonies, which do not contain
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recombinant molecules in the experiment. Calf intestinal phosphatase (CIP) was provided from
Boehringer Mannheim. For incubation procedure the use of 1U per 1-100 pmoles DNA is
recommended. One unit of CIP was defined as the enzyme activity which hydrolyses 1 µmol
of 4-nitrophenyl phosphate in 1 min at 37°C under assay conditions.
Reaction mixture for DNA - dephosphorylation:
50 µl (8 µg) DNA
6µl CIP (1U/µl)
6µl dephosphorylation - buffer 10 x
Dephosphorylation buffer 10x:  0.5 M Tris/HCl, 1mM EDTA, pH 8.5
DNA - dephosphorylation using calf intestinal phosphatase (CIP) was carried out at
37°C for 60 min. The reaction was stopped by heating the mixture at 65°C for 10 min in
presence of 5 mM EDTA, before purifying the phosphatase-treated DNA by QIAquick PCR
purification.
3.5.2.2.3. DNA-gel extraction with Qiagen-kit
The recovery of the after electrophoretic separation was achieved using QIAquick Gel
Extraction - Kit (Qiagen).  This system combines spin – column technology with the selective
proprieties of a “silica” – gel membrane.
The desired DNA – fragment was excised from the agarose gel under UV-light (UV –
handlampe, 312 nm) and weighed. The gel slice (1 volume) to which was added QG – buffer
(3 volumes) was incubated at 50°C, until agarose was completely dissolved (about 10 min). If
the colour of the mixture changed from yellow 3M NaOAc pH 5 (10 µl) were added and
mixed. If extraction of DNA fragments larger then 4 kb was desired, 100% isopropanol (1
volume) was added to the sample and mixed. From this mixture, a maximum amount of 400
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mg - gel slice was applied per a QIAquick centrifugated for 1 min at 10000 g. Traces of
agarose were removed with QG – buffer (500  µl) and centrifugation. Salt traces were
removed by washing with PE – buffer (750 µl) and centrifugation. An additional centrifugation
(1 min, at 10000 g) was performed to remove residual ethanol from PE – buffer. DNA was
eluted with 50 µl EB – buffer or H2O (pH 7 – 8.5) and stored at –20°C. Since EDTA may
inhibit subsequent enzymatic reaction, TE was not used as elution buffer.
EB - buffer: 10mM Tris/HCl, pH 8.5
3.5.2.2.4. Construction of recombinant DNA molecules
An appropriate digested target and vector DNA were linked together in a
recombinant molecule prior to transfer to E.coli in a DNA-ligation reaction.
DNA ligase links fragments of DNA, containing blunt-end and cohesive-end termini,
to each other in a covalent manner. It catalyses the formation of a phosphodiester bound
between juxtaposed 5’ phosphate and 3’ hydroxyltermini in duplex DNA. Recommended
total DNA concentration in a plasmid cloning experiment is of maximum 1 µg/ml (Gannon
and Powell, 1991). The cohesive end - ligation was performed for a mixture contained 1 : 3 =
vector: DNA fragment. The molar ratio was increased for bunt – ligation.
For ligation reactions T4 - DNA Ligase (400,000 U/ml, provided from New England
Biolabs) was used. One NEB unit of T4 DNA ligase was defined as the amount of enzyme
required to give 50% ligation of Hind III fragments of Lambda DNA in 30 minutes at 16°C in
20µl assay mixture and 5’DNA termini concentration of 0.12µM (300µg/ml).
The ligation mixture was incubated at 16°C over night. Optional, T4 DNA ligase was
inactivated at 65°C for 10 min and ligation products were transformed into bacteria. The
correct and complete ligation was analysed by gel electrophoresis with unligated material as a
marker. Recombinant DNA was stored at –20°C.
3. MATERIALS AND METHODS
______________________________________________________________________
64
DNA – ligation mixture:
1 µl T4 - DNA Ligase
1 µl T4 - DNA Ligase – buffer 1x
x µl DNA fragment
y µl vector
till 10-20 µl H2O
Ligase – buffer (1x):
50 mM Tris/HCl pH 7.5, 10 mM MgCl, 10 mM DTT, 1 mM ATP, 25µg/ml BSA
3.5.2.2.5. Radioactively labelling a DNA-probe
Labelling DNA with 32P
Radioactively labelling a DNA-probe for northern analysis was performed for
APE1 gene which was isolated from a plasmid, p313/LAP.
To about 25 ng DNA add H2O to a final volume of 45 µl, incubated at 95°C for 2-5
min and then cool down on ice. Transfer all to a cup of lyophilised labelling - premix
(containing dATP, dTTP, dGTP, buffer, Klenow Polymerase and hexameric primers) and re-
suspend carefully. Add 2.5 – 5 µl of a-32P-dCTP and incubate for 10-15 min at 37°C.
Probe DNA purification
Labelled DNA probes were purified to determine the specificity of the labelling
reaction. Purification procedure was based on filtration through a Sephadex G.50 column. The
product was eluted with TE (or H2O).
First, a Sephadex G.50 spin column in TE buffer was prepared: glass wool placed in a
blue-pipette tip and Sephadex G.50 in TE was added. The tip was centrifuged at 3500 rpm,
for 2 min in Haeraus centrifuge. Then, the buffer was discarded and into the column, the
sample plus 100 µl TE was loaded and centrifuged (under the same conditions). The sample
was collected and 1/100 of it was monitored measuring Cerenkov reaction (efficiency of
52%).
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3.5.2.2.6. QIAquick PCR purification of PCR-products
 QIAquick PCR purification kit from Qiagen is designed to purify single- and double-
stranded DNA fragments (ranging from 100 bp to 10 kb) from PCR and other enzymatic
reactions. This kit was used for cleaning up DNA from alkaline phosphatase reaction. PB –
buffer (5 volumes) was mixed with products mixture of alkaline phospatase reaction (1
volume), loaded to the QIAquick column and centrifuged (10000 g, 1 min). Washing with PE
– buffer (750µl) and an additional centrifugation to remove residual ethanol  (10000 g, 1 min)
were performed. DNA was eluted with 50µl EB- buffer and used direct for E.coli
transformation or stored at –20°C.
3.5.2.3.      DNA-sequencing
3.5.2.3.1. Cycle Sequencing with Dye – Terminator
Plasmid DNA subjected to DNA sequencing was purified using mini-prep Qiagen kit,
quantified spectrophotometrically and amplified with a 25 cycles polymerase chain reaction
(PCR) in a thermoblock (Mastercycler gradient, Eppendorf.).
For PCR reaction dsDNA was mixed with primers (forward or reverse primers), a
premix (that contains DNA polymerase, dNTP- mixture, ddNTP-mixture and buffer) and
H2O.
PCR reaction mixture:
0.25 – 0.5µg double strains DNA
2µl 30 mg/µl primers
4µl premix buffer
till 20 µl H2O
For purification of amplified DNA from residual reaction components, PCR product
(20 µl) was mixed by vortexing with NAACO (2µl of 0.3M) and ethanol (50µl of 100%),
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stand on ice for 10 min, and centrifuged at 13000 rpm, 4°C for 20 min. The supernatant was
discarded and DNA pellet washed with 70% ethanol (250 µl) and dried on Speed vacuum.
DNA was re-suspended in 2.8 µl formamid / EDTA (5:1).
3.5.2.3.1. DNA-Sequence analysis
Amplified DNA fragments for DNA-Sequence analysis were sent to a service
laboratory where were solved on polyacrylamide gels and monitored by computer software.
The DNA - sequence was analysed using yeast data bank available on the Internet.
3.5.3. RNA analysis
3.5.3.1. Total yeast RNA extraction using RNAeasy kit
Total yeast RNA was extracted using RNAeasy kit, which was purchased from
Qiagen. Before and during RNA-extraction RNase-free environment was maintained
conforming to supplier advice: working in aseptic conditions and wear of gloves while handling
reagents and RNA samples to prevent RNase contamination; using sterile, disposable plastic
ware RNase-free. Non-disposable plastic ware, glassware and electrophoresis tanks were
treated to inactivate RNases with 0.1 M NaOH (12 hours at room temperature) followed by
RNase-free H2O. RNase-free H2O was obtained by treating deionizated H2O with 0.1%
DEPC and autoclaving (to remove residual DEPC). All solutions were prepared using H2O
treated with DEPC.
Total yeast RNA extraction was done from 5 OD cells (equivalent to 5 x107 cells) in
early log-phase growth. The principle of RNA extraction is summarised in figure no. 3-5. Total
yeast RNA extraction was performed after RNeasy Mini Handbook 03/97, Qiagen. All steps
were done at room temperature.
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Buffers for yeast RNA extraction:
Buffer Y1
1M Sorbitol
0.1M EDTA pH7.4
Before use, 0.1% ß-ME and 50U Lyticase/Zymolase were added per 107 cells.
Buffer RPE was supplied as a concentrate. Before using, 4 volumes of ethanol (96-
100%) were added to obtain a working solution.
Buffer RLT was checked for precipitate formation. If necessary, it was worm to re-
dissolve. Before use, 10µl ß-ME per 1 ml of buffer RLT were added to obtain a
working solution.
Figure 7: Scheme of RNeasy Mini Procedure
Cells were harvested for 15 min at 1000x g in Heraeus centrifuge at 4°C and the
supernatant completely removed. This was done to avoid inhibition of cell wall digestion in
next step. Cell pellet was re-suspend in 2 ml enzyme-containing Buffer Y1 and incubated for
10-30 min 30°C with gentle shaking to prepare spheroblasts. Complete spheroblasting was
Homogenize sample to shear genomic DNA and reduce viscosity of lysate
Add ethanol to adjust binding conditions
Apply sample to RNeasy spin column for adsorbtion of RNA to membrane
Remove contaminants with simple wash spins (buffers RW1,RPE)
Elute ready-to-use RNA in water
Disrupt and lyse yeast cells with GITC-containing buffer (buffer RLT)
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essential for efficient lysis. Spheroblasts were pelleted by centrifugation for 5 min at 300x g.
Lysis of the spheroblasts was performed in 350µl buffer RLT and vigorously vortexing. If
necessary, the lysate was centrifugated for 2 min at 3000 rpm in Heraeus centrifuge to collect
insoluble material. The supernatant was transferred to a  microfuge tube. 1 volume of 70 %
ethanol was added and mixed well. The sample (usually 700µl) including any precipitate which
might have formed, was applied to an RNeasy mini spin column sitting in a 2-ml collection tube
and centrifugated for 15 sec at 8000x g. More washing steps were performed. First washing
was done with 700µl Buffer RW1 onto the RNeasy column by centrifugation (15 sec at
8000x g). Second washing was done with 500 µl buffer RPE onto the RNeasy column by an
identical centrifugation. For last washing, 500 µl Buffer RPE were applied onto the RNeasy
column. This was centrifugated for 2 min at maximum speed to dry the RNeasy membrane.
RNA was eluted with 30-50 µl of RNase-free H2O by centrifugation for 1 min at 8000x g.
Total RNA was stored at –70°C in H2O.
3.5.3.2. Separation of RNA in formaldehyde-agarose
3.5.3.2.1. RNA sample
RNA sample (4 volumes) was diluted with 5x RNA loading buffer (1 volume),
incubated for 3-5 min at 65°C, chilled on ice, and loaded onto equilibrated FA gel.
5x RNA Loading Buffer (stabile three months at 4°C)
16 µl saturated bromophenol blue
80 µl 500 mM EDTA, pH 8.0
720 µl 37% formaldehyde
2 ml 100% glycerol
3084 µl  formamid
4 ml 10x FA gel buffer
till 10 ml RNase-free H2O
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3.5.3.2.2. Formaldehyde – agarose (FA)  gel electrophoresis
Formaldehyde – agarose (FA) gels were prepared from agarose melted in microwave,
2O bath, mixed with 1.8 ml of 37% (12.3 M) formaldehyde and 1 µl of
ethidium bromide (10mg/ml) and poured into gel support. Prior running, the gel was equilibrate
in 1xFA gel running buffer for at least 30 min. Formaldehyde – Agarose (FA) Gel
Electrophoresis was done at 5-7 V per cm with 1x FA gel-running buffer.
10x FA Gel Buffer (pH 7.0):
200 mM MOPS
50 mM Sodium acetate
10 mM EDTA
MOPS (20.93 g), sodium acetate (0.205 g) and EDTA (0.186 g) were dissolved in
500 ml RN-ase free H2O. The pH was corrected with NaOH.
1.2% FA Gel
For 100 ml: 1.2 g  Agarose
10ml  10xFA Gel Buffer
1x FA Gel Running Buffer:
100 ml 10x FA Gel Buffer
  20 ml 37% Formaldehyde
880 ml RNase-free H2O
3.5.3.3. Northern blot analysis
3.5.3.3.1. RNA blotting. Assemble the Northern blot sandwich
RNA can be transferred by capillary action, vacuum blotting and electro-blotting.
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Using the classic capillary transfer method, transfer time of about 12 hours was required
to achieve high transfer efficiency.
Blot storage
Blots were used immediately or stored at room temperature.
Figure 8: Schema of capillary transfer of RNA by Northern blot.
   The arrow shows the direction of liquid-stream
3.5.3.3.2. Fixation of RNA onto membrane
Baking, alkali and UV irradiation are procedures that may be used function of
the type of the membrane.
RNA was immobilised on a nylon hybridisation transfer membrane (HybondTM-N)
using the UV cross-linking technique. RNA-molecules were immobilised by covalent binding
between light-activated nucleotides and C = C groups on the membrane surface. Because the
binding of the molecule is UV dose dependent and over exposure of the blot may result in
buffer
filterpaper on glass plate
gel
Hybond N- membrane
3x filter paper
stack of paper towels
glass plate
weight (1kg)
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complete binding of the molecule and decreased hybridisation capacity, the blot was exposed
to UV light only 10-15 sec. Membranes were dried thoroughly, at 65°C for 20 min.
3.5.3.4. Hybridisation of RNA
3.5.3.4.1. Membrane hybridisation with a labelled-DNA probe
DNA, RNA and synthetic oligonucleotides can all be used as probes in
membrane hybridisation experiments.
Shortly, a membrane on which RNA has been blotted was incubated with a
hybridisation solution containing the labelled-DNA probe (see Radioactively labelling a DNA-
probe). To reduce non-specific binding of the probe the membrane was washed after
hybridisation at controlled temperature, salt concentrations and detergents. Well-matched
hybrids could be washed at high stringency conditions (0.1x SSC); whereas poorly matched
hybrids were washed in lower stringency conditions (2-6x SSC). 1-2 µCi / ml radioactively
labelled-DNA probe in hybridisation-mix solution (H-S) were used. The membrane was
rolled, with the face on which have been blotted RNA to the inner centre, into a 50 ml Falcon-
tube. 2-5 ml H-S sspDNA and labelled-DNA probe were added. The mixture was prepared
as follow: in an Eppendorf cup, to 1 ml of H-S add 100 µg ssp DNA (see Appendix) This
was incubated at 95 °C until labelled-DNA probe was added and further incubated to 95°C
for 3 min.  Afterwards, all was added to H-S into the Falcon tube containing the membrane
and hybridise over night, on a shaker at controlled temperature of 42°C.
 Second day the washing of the membrane was performed in 2x steps. First, with a 2x
SSC, 0.1% SDS, at room temperature for 15 min or more. The membrane should have not
more than 25 cpm radioactivity before the second washing which has to be done at 65°C,
with 0.2x SCC, 0.1% SDS, for 15 min.
20 x  SSC - buffer, pH 7.0:
3M  NaCl
0.3 M  Na3Citrate x 2 H2O  
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For 1 l SSC - buffer 20x, NaCl (175.3 g) and Na3Citrate x 2 H2O (88.2 g) were
dissolved in 800 ml H2O. The pH was corrected to 7.0 with 1M HCl and H2O was added to
final volume.
Hybridisation-mix solution (H-S):
72 ml Formamid
36 ml 20x SSC
1.5 ml 1M Tris/HCl, pH 7.5
1.5 g SDS
3 ml 50x  Denhardts
30 ml 50% Dextransulfat
First, 15 g Dextransulfat were added to ddH2O within a final volume of 30 ml and
were solved at 80°C.  Subsequently, there were added the other substances.  At the end,
ddH2O was added to a final volume of 150 ml.
3.5.3.4.2. Detection techniques of  RNA-DNA complexes
RNA bands complementary to radioactively marked DNA probe were visualised by
membrane-exposure to a phosphoimager screen with Phosphoimager, IPR 1000 (Fuji BAS
1000). The analysis was performed with computers’ programs like ImageReader and
ImageGouge.
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4. RESULTS
4.1. Isolation of Ape1p transport mutants
Aminopeptidase 1 (Ape1p) is synthesized in the cytoplasm as an enzymatically
inactive precursor protein, pApe1p, which is proteolytically processed when reaching the
vacuolar lumen yielding the mature form (mApe1p). This processing and a dodecamerisation
of the monomer are required for Ape1p enzymatic activity (Metz et al., 1977)
4.1.1. Screening strategy for mutant isolation
Isolation of pApe1p transport mutants was based on non-specific and aleatoric
DNA mutagenesis of a wild type strain and selection of yeast mutants defective in a particular
transport step. The mutant gene will be isolated by complementation cloning (figure 9).
Figure 9: Screening strategy for mutant isolation
wild type strain
DNA - mutagenesis
mutants for multiple DNA sites
SELECTION
mutants defective in APE1 - transport steps
isolation of mutated gene
  COMPLEMENTATION CLONING
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4.1.2. Isolation of mutants deficient in Ape1p activity
A wild type strain (II.17) lacking four aminopeptidase activities was transformed with
the APE1 gene (LAP IV) under the control of its endogenous promoter isolated from a
genomic DNA library on a single-copy plasmid (p314/LAP, trp+). The new strain (YCB 18:
Dape1, Dape2, Dape3, Dape4, pAPE1-Trp) showed wild type levels of Ape1p expression
and activity, indicating that processes like translation, transport and maturation of
aminopeptidase 1 occurred normally. The enzymatic activity of Ape1p in these strains was
quantified using Ape1p-overlay activity test for yeast colonies. Transformation of II.17 with
two independent replicating single-copy plasmids carrying the APE1 gene demonstrated that
the ‘overlay’ activity allows detecting alterations of 25% of the wild type enzymatic activity.
The level of activity was set to 0 for II.17 and +4 for YCB 18.
YCB 18 was EMS – mutagenized and clones devoid of Ape1p activity were isolated.
In figure 10, the isolation of Ape1p – transport mutants is summarised on a flow chart (panel
A) and the Ape1p ‘overlay’ assay used for their isolation as shown on panel B.
The EMS – mutagenesis was carried out by incubating YCB 18 - cell suspension in
0.1 NaPi pH 7.4 with 33% (v/v) EMS for 30 min at 30°C.  Mutagenized cells were plated on
YPD- medium plates as single colonies. Since the chromosomal APE1 gene was disrupted,
the mutants isolated could carry mutations in genes responsible for Ape1p processing, i.e.
transcription, translation, transport, maturation as well as of the APE1 gene introduced on the
Trp-plasmid. Mutagenized cells, which grew on YPD, were replica plated on selective minimal
medium containing all supplements except tryptophan (MV-Trp) to select for the ectoptic
APE1 gene. From these plates replica were made on chromatography papers, which were
placed on rich media plates (YPD) to avoid upregulation of unspecific autophagocytosis. After
incubation of the filters overnight at 30 °C, colonies were screened for loss of Ape1p activity
by the ‘overlay’ assay. Clones devoid of Ape1p activity were isolated.
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Panel A
Panel B
Figure 10: Flow chart of Ape1p – transport mutant isolation (panel A)
    (details in text)
    Ape1p overlay activity assay (panel B)
Image recorded at 365 nm using CCD camera. Strains with Ape1p enzymatic ac-
tivity emit fluorescent light and colony streaks become visible. Strains shown: the
original mutant (without Ape1p - activity) and wild type (with Ape1p - activity).
(D  ape1-4, pAPE1 - Trp )EMS mutagenesis of YCB
18 (
growth on YPD
replica on MV - Trp
replica on
filter and
growth on
YPD
Ape1p -’overlay’ assay
test for CPY - activity
retransformation with pAPE1 - His
Ape1p -’overlay’ assay
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Ape1p is activated by the same endopeptidases, proteinase A (PrA) and proteinase B
(PrB), as two other vacuolar enzymes carboxypeptidase Y (CPY, soluble protein) and
carboxypeptidase S (CPS, membrane anchored protein). Therefore, clones lacking Ape1p
activities were further assayed for an intact secretory pathway and the presence of the
activating vacuolar enzymes, PrA and PrB by testing for CPY and CPS enzymatic activities in
a micro-titer plate assay (P.Schu, unpublished). This allowed identifying and excluding
mutants defective in vacuole biogenesis. In order to test for the mutagenesis and expression of
the APE1 gene introduced by Trp-plasmid, mutants were re-transformed by a second APE1
gene on a single - copy plasmid (p313/LAP, his+), after they had lost the trp-plasmid.
In the table 15, the statistics for the isolation of pApe1p-transport mutants are
presented. The number of cells which survived EMS – mutagenesis, was set to 100%. From
these only 60% still contained a functional Trp-plasmid. 0.6% of the colonies carried mutations
which affected the expression of Ape1p enzymatic activity. Only 18% of these had an intact
vacuole. After retransformation 14 mutants, which represent 0.07% of the original colonies,
were selected for analysis by yeast genetics.
Table 15:  Statistics for the isolation of pApe1p - transport mutants by Ape1p activity
Colonies
on  YPD
Colonies on
selection-
medium
Clones
without
activity
Clones
positive for
CPY –CPS
activities
Clones
without any
activity
Clones with
reduced
activity
135000 80000 850 150 93 57
0.07%
0.04
100% 60% 0.6% 0.1%
after
re-transfor-
mation
14 mutants
?
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4.2. Selection of mutants deficient in Ape1p transport
Since the mutations were induced aleatoric, and therefore have been expected to
affect multiple genes, an approach based on non-specific recombination of the genes was
taken. Successively mutant-strains were mated with wt-strains, diploids were isolated and
tetrads dissected (figures 11, 12). The isolated spores were assayed for mating type, Ape1p
activity and expression of Ape1p.
Figure 11: Successive gene recombination for isolation of Ape1p – transport mutants
    The EMS-original mutants were all MATa. Successively mutant-strains were mated
    with wt-strains, diploids were isolated and tetrads dissected. The cycle for repairing
                mutated DNA, based on gene recombination was repeated until 2:2 segregation of
    the mating type and phenotype concerning Ape1p activity was obtained.
diploid (a/a)
incomplete tetrad (a,a,a)
diploid (a/a)
complete tetrad (a,a,a,a)
diploid (a/a)
tetrad (a,a,a,a) 2:2 segregation
Tetrad dissection
Mating
GENE RECOMBINATION
Sporulation
mut (a)
wt (a)
wt (a)
mut (a)
1st round
2nd round
3rd round
Tetrad dissection
Mating
GENE RECOMBINATION
Sporulation
Tetrad dissection
Mating
GENE RECOMBINATION
Sporulation
mut (a) wt (a)
wt (a)
mut (a)
mut (a) wt (a)
mut (a)
mut (a)
wt (a)
mut (a) wt (a)
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Figure 12: Image of tetrad dissection on YPD – plate
Sporulated cells were re-suspended in 100 µl H2O; 200 U of b-glucoronidase was
added and the suspension was incubated 20 min at 37°C. With a needle controlled by
a micromanipulator ascii were separed from unsporulated cells and spores were iso-
lated and aligned (on positions A, B, C, D) on a YPD plate. Each set of 4 spores
corresponds to a tetrad (named 1, 2, 3, etc). The segregation of growing phenotype
can be seen in tetrads named 2, 4 and 5. Growth defects can be seen in the tetrads
named 1, 3 and 6.
To ensure intragenic recombination, in each round of mating, the mutant spore of a
different mating type than the parent mutant was used for subsequent tetrad analysis.
Therefore, two wt strains were required. The genesis of the two wild types (wt), C6A (a) and
C6C (a), used for gene recombination is described further.
Isogenic strains of opposite mating type, deficient in the 4 leucineaminopeptidases
were generated by mating II.17 with SEY6211. Sporulation was induced by acetate, and
spores (MATa and MATa) were randomly selected (P. Schu, unpublished). The APE1 -
gene on two different plasmids (p313/LAP, his+, p314/LAP, trp+) was expressed in these
spores. Transformants, named PSY13/LAP and PSY3/LAP, were mated. After tetrad
dissection spores were tested for leucine-aminopeptidase activities using the overlay – assay
(figure 13).
Leucine-aminopeptidase deficient strains did not show any phenotype related to
vacuolar functions, as growth under nitrogen limitation and sporulation. C6A (MATa, lap+4)
and C6C (MATa, lap+4) were used for via – mutants selection.
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Figure 13: Genesis of C6A (a) and C6C (a )
    (details in text)
When C6A was mated with C6C, complete tetrads were achieved and all four
isolated spores (v1, v2, v3, and v4) had lost the his-plasmid. Once pAPE1-His was
introduced they show wt - level for Ape1p expression and activity. Spore v1 was used as
negative control for characterisation of via – mutants.
Since a mutant (Trp+) was mated with a wild type (His+) diploids selection was based
on complementation of nutritional requirements. Meiosis was induced by plating diploid cells
on medium without nitrogen and with 1.47 % acetate as carbon source. Separation of the
spores from ascus was performed using a micromanipulator (Zeiss) for tetrad dissection. At
first round of tetrad dissection, only incomplete tetrads (3n) were isolated. This fact shows that
the mutagenesis might have affected also genes involved in cell differentiation. Up to 4
successive rounds of crossing with wt, sporulation and tetrad dissection were performed. In
the last round of dissection the phenotype of the four spores was 2:2 with respect to mating
type and Ape1p activity. The four spores were shown to carry either one of the plasmids,
(Trp+) or (His+), or both.
From the isolated 14 EMS – mutants, two did not form diploids (EMS-mutants:
II.17(a)      +      SEY 6211(a)
SPORULATION.  RANDOMLY SPORS’ SELECTION
PSY 13                    PSY 3
+ pAPE1-His
C6A (a), C6B, C6C (a)
PSY13/LAP             PSY 3/LAP
+ pAPE1-Trp
SPORULATION. TETRAD DISSECTION
+
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1.87, 12.126) and other three did not sporulate (EMS-mutants: 11.15, 12.126, 17.314) after
crossing with wild type. One mutant (10.75) turned all four spores to wt – phenotype after first
round of sporulation, indicating accumulation of synergistic mutations. 8 mutants were analysed
further. Six of them reached the isolation stage of complete tetrad and showed 2:2 segregation
for Ape1p – activity. With the exception of via14, one to three spores from all other tetrads
lost the His-plasmid during selection. Therefore those spores had to be re-transformed with
p313/LAP plasmid. Due to the screening and selection strategy, the isolated mutants were
named via - mutants, for Vacuolar Import and Autophagocytosis. They were generated from
the EMS-mutants, named: 7.511
Table 16: Genesis of via3, 10 and 14 – mutants. Mating type, phenotype and origin
Mutant Number of
Tetrads
Dissected
Spores
Mating
Type
Phenotype:
Ape1p-
‘overlay’  test
Origin:
EMS-mutant
one
3 III A
3 III B
3 III C
3 III D
a
a
a
a
lap-
lap-
lap+4
lap+4via3
one
3 IV A
3 IV B
3 IV C
3 IV D
a
a
a
a
lap+4
lap+4
lap+1
lap+1
20L14
(a, trp+, lap-)
10 II A
10 II B
10 II C
10 II D
a
a
a
a
lap+4
lap+1
lap+4
lap+1
via10 two 10 II A’
10 II B’
10 II C’
10 II D’
a
a
a
a
n.d.
n.d.
n.d.
n.d.
1.112
(a, trp+, lap-)
one
14 II A
14 II B
14 II C
14 II D
a
a
a
a
lap-
lap+4
lap+4
lap-
via14
one
14 III A
14 III B
14 III C
14 III D
a
a
a
a
lap-
lap+4
lap-
lap+4
9.38
(a, trp+, lap-)
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(via1), 24.37 (via2), 20L14 (via3), 21.412 (via7), 1.112 (via10), 9.38 (via14). So far, 3 of
those were further characterised: via3, via10 and via14.
4.2.1. Specific activities of vacuolar enzymes
During the screening procedure enzymatic activities were determined by plate assays
to test large numbers of colonies. Specific activities of vacuolar enzymes (Ape1p and CPY) in
via10 and via14 mutants were determined to verify the data collected by plate assays.
Crude protein extracts were prepared from cells grown in YPD medium to mid-log
phase and stationary phase by similar procedure as for western blot analysis omitting protease
inhibitors and including at the end, an additional centrifugation of 5 min, at 13000 rpm. CPY
and Ape1p - enzymatic activities were calculated from initial velocity of the reaction over the
first 15 minutes. Not more then 150 µg of total extract per assay was applied.
The Ape1p – activity was assayed with H-Leu-pNA as substrate and ZnCl2 was
present to stabilise mApe1. Enzymatic activity was followed for 30-45 min at 30°C. via14
and via10 have showed 0-20 % of the wild type activity in stationary growth conditions (table
16) where enzymatic activity of mApe1p reaches its maximum - as it was measured in
overlays assay. The Ape1p – activity in exponentially growing cultures was reduced on
average by only 30% (1.6 mU/mg) compared to stationary growth conditions (2.08 mU/mg)
in wild type (C6C). It was noted, that in protein extract from stationary growing cells, via14
appeared to have 15% more activity than via10, which contrasts the data from the overlay
tests (table 15). This result may be explained by efficient stabilisation of mApe1p by Zn2+
present in the assay mixture or that mApe1 in via14 is more sensitive to the CHCl3 used to
permeabilize the cells in the overlay assay.
CPY activity was measured in cell extracts where it forms a complex with a
cytoplasmic inhibitor. CPY has to be activated prior incubating with substrate leading to
variations of data values from experiment to experiment.  However, under exponentially
growth conditions (table 18) via10  showed 70% of the wild type CPY- activity and
exceeded with 45% that of wild type in stationary growth conditions.  via14 showed 80 -
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85%  of  wild type CPY activity under exponentially growth conditions and exceeded with
25% the activity of  wild type. From these results we could conclude that in via - mutants
accumulation of the precursor form of aminopeptidase 1 is not due to a defective vacuolar
processing machinery.
Table 17: Ape1p specific activity in via - mutants in stationary growth conditions
STRAIN CONTROL via14 via10
Ape1p specific activity under
stationary growth conditions
(mU/mg)
2.38
±0.15
0.89
±0.4
0.45
±0.15
Table 18: CPY specific activity in via-mutants under logarithmic and stationary growth
   conditions
STRAIN CONTROL via14 via10
CPY – specific activity under
logarithmic growth conditions
(mU/mg)
0.61 0.50 0.42
CPY – activity under stationary
growth conditions
(mU/mg)
0.47 0.58 0.67
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4.3. Characterization of via - mutants
4.3.1. via - Mutants accumulate pApe1p
via - Mutants were isolated based on the absence of Ape1p enzymatic activity.
Expression and processing of Ape1p were analysed by SDS-PAGE and western blot. Protein
extractions were performed from yeast cells growing on YPD – medium to mid-log phase to
avoid induction of bulk autophagocytosis. A defect in the transport of pApe1p to the vacuole,
should result in a defect in maturation and accumulation of the precursor form.
Crude extracts were prepared from the strains in the presence of protease inhibitors to
block in vitro pApe1p processing. Proteins were separated by SDS-PAGE, blotted onto
nitro-cellulose membranes and precursor and mature Ape1p were detected using a rabbit anti-
Ape1p antiserum.
Wild type cells showed 30% pApe1 and 70% mApe1 under logarithmic growth
conditions (OD600 = 0.8 – 1.2) in rich media (YPD) while less then 10% pApe1p can be
detected in stationary cultures (OD = 2.2 – 2.5) (figure 15).
In via10 up to 70% of Ape1p accumulated as pApe1p, while in via14 up to 80% of
Ape1p was found as pApe1p under logarithmic growth conditions (figures 14, 15).  Under
stationary growth conditions pApe1p levels were reduced in via10 and via14 by 5-10%.
The same ratio of precursor protein to mature under logarithmic and stationary growth
was found in via3 (figure 16), however expression level is drastically reduced (see chapter
4.3.3). These results indicate that in via-mutants autophagocytosis can be up-regulated under
starvation conditions. This reduction corresponds to the change seen in wild type cells, but it
can not compensate the defects observed under logarithmic growth conditions.
In figure 14 is shown the accumulation of pApe1p in via10 – mutants, under the
logarithmic growth conditions, in YPD. Wild type and via10 spores, which were positive
spores for Ape1p activity (10 II A, 10 II D) do not accumulate pApe1p.
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pApe1p
mApe1p
Tetrad  10.II.  KO         C6C
  A          B  C    D
Figure 14: Western Blot analysis of the via 10-tetrad
Cell cultures were grown until exponentially growth phase in YPD. The positive
spores in Ape1p overlay assay (10 II A and 10 II D) and wild type strain convert
up to 80% Ape1p to mature form while negative spores accumulate mainly pApe1p.
KO designates a control strain having APE1 disrupted.
C6C via14
FL    FS      FL       FS
pApe1p
mApe1p
30  10   60        50
70       90             40        50
% pApe1p
% mApe1p
Figure 15: Western Blot analysis of the via14 mutant and wild type (C6C) in logarithmic
    and stationary cultures
      Protein extract (65µg applied per each lane) was separated in 10% SDS-PAGE,
    blotted on nitro-cellulose membrane and developed with 1:1000 antibody against
    Ape1p in 5% milk in TBS-Tween 1x. On the figure, FL corresponds to protein
    extract in exponentially growth phase in YPD and FS to stationary growth phase.
pApe1p
mApe1p
Figure 16: Processing and expression level of pApe1p in via3 mutants and wild type
    (C6C) under logarithmic and stationary growing (Western Blot analysis)
     Protein extract (90µg applied per each lane) was separated in 10% SDS-PAGE and
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    blotted on nitro-cellulose membrane. The blot was developed with 1:1000 antibody
    against Ape1p in 5% milk in TBS-Tween 1x.
4.3.2. via – Mutants define two complementation groups
To avoid working with mutants of the same genes, complementation tests were
performed for via3, via10 and via14. A complementation test consists in the introduction of
two mutant chromosomes from cells with similar phenotype, simultaneously into the same cell
and looking for the complementation of the genes. Lack of complementation for two mutations
is indicative of allelism.
Gene complementation was assayed using pApe1p - overlay test for diploids
generated by mating of via- mutants with each other and with wt cells (figure 17).
C6C        via14-B
+                 +
-  via14-AOM -
+             +
C6C/via14-A      via14-A/via10-B
Figure 17: Complementation test based on Ape1p-overlay activity
The Ape1p- overlay activity assay of a mutant (via14-A) and two diploids (via14
A/via 10-B, via14-A/wt).  To achieve contrast, yeast cells were replica plated on
black paper. The picture was taken at 365 nm using a CCD camera. Strains with
Ape1p enzymatic activity emit fluorescent light and colony streaks become visible.
With OM was marked the original mutant isolated from the screen. via14-B spore
is positive and via14-A negative for Ape1p activity. C6C is the wt strain. The
Ape1p activity recorded for the diploid of wt/via14 and via10/via14 are similar to
C6C.
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Since all via-mutants have the same marker for auxotrophy, His+, the selection for
diploids was based on morphology. Diploid cells are larger then haploid cells and so are
colonies of diploids. After mating cells were streaked on YPD plates to form single colonies.
Cells from the largest colonies were tested for diploidy by testing their ability to mate with a or
a cells.  Lack of mating indicates diploid formation. In table 19, the Ape1p activity of the
isolated diploids is summarised. Mating of two Ape1p negative via14 spores did not restore
Ape1p activity as expected. The diploids resulting from mating via14 with via10 had
enzymatic activity similar to wild type demonstrating that different genes are mutated. Crossing
of via3 with via14 did not lead to diploid formation. Mating of via3 with via10 did not show
gene complementation. This indicates that via3 and via10 belong to the same
complementation group. Alternatively, via3 could carry a dominant negative allele. The
Ape1p-activity recorded for the diploid of wt and via-mutant was always similar to wt.
Therefore, two classes of pApe1p transport mutants have been identified: via10 and via14.
Table 19: Complementation tests for via3, via10 and via14
Complementation tests
Ape 1 – overlay
 assay of diploid
via14 x via14:
14.II.D x 14.III.A
(negative)
via14 x via10:
14.III.A x 10.II.B
+3/+4
via14 x via3:
14.III.A x 3.III.A
no diploids
via10 x via3:
10.II.B x 3.III.B
+1 / +2
via14 x wt:
14.III.C x C6C
+4
via10 x wt:
10.II.B x C6A
+3
via3 x wt:
3.III.A x C6A
+3
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4.3.3.  Evidence that via3 is a transcription - mutant
It is known that vacuolar proteolysis is important for the survival and differentiation of
the organism. Diploids lacking vacuolar proteases fail to sporulate (Teichert, et al., 1989).
a b
c d
e f
g h
wt
via10
via14
via3
Figure 18: Vacuolar morphology among the via-mutants
Nomarski optical images (in the left column: a, c, e) and the corresponding
fluorescence signal due to vacuole staining with CL2CFDA (in the right column: b, d,
f, h). Cells, which were grown until mid-log in YPD, re-suspended in Na+-Citrate
(50mM pH 4) with CL2CFDA (1µl of 10mM in DMSO) were incubated at 30°C 10
min, harvested and re-suspended in 0.1 M NaPi pH 7.5, 2% glucose. Visualisation
was performed using a Zeiss Axiovert 100 equipped with a PlanNeofluar 63x/1.25.
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As shown on table 18, via3 mutants could be mated with via10, but not with via14.
No or very low efficiency of diploid formation indicates severe physiological defects in via3.
Staining of vacuoles with a fluorescent dye which accumulates in acidic compartments revealed
a large number of small acidic compartments in via3, whereas wild type cells and via10 and
14 contained only one or two vacuoles (figure 18).
In western blot analysis, CPY expression level was equal in all four via3 spores (figure
19) while APE1 expression varied from wt-level for positive spores and very low for mutant –
spores (figure 16). This indicates that the defect is specific for pApe1p transport pathway.
Reduced expression levels could be caused by increased instability of the protein or by
reduced transcription/translation rates.
    3  I V A         3  I V  B             3  I V  C          3  I V  D
  F L     F S      F L     F S           F L     F S        F L      F S
C P Y
Figure 19: CPY expression level among via3 spores
    Protein extract (65µg applied per each lane) was separated in 10% SDS-PAGE, blot on the
     nitro-cellulose membrane and developed with 1:10000 antibody against CPY in 5% milk in
     TBS-Tween 1x.
To investigate if via3 is a transcription mutant, the relative abundance of APE1-
mRNA of negative and positive spores of the via3-tetrad and wild type was determined.
RNA extracted from early exponentially growing cultures in YPD-medium, was subjected to
Northern blot analysis. The entire APE1 – gene was used as a DNA-probe. APE1- probe
was isolated from p313/LAPIV plasmid with XhoI endonuclease and gel extraction by
Qiagen. The labelling reaction was performed with 32P-dCTP. 2µCi labelled probe (4.4x106
cpm) in 3 ml hybridisation solution was used for blot hybridisation. Visualisation was
performed using a Phosphoimager model Fuji IPR 1000 and Image Reader and Image Gauge
software. The fluorescent image of the RNA gel demonstrates that equal amounts of RNA
have been loaded on the gel (figure 20). APE1 gene has an ORF of 1544 bp and together
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with upstream sequences until the TATA box measures about 1800 bp. In the figure 21, the
intensity of the upper band (a non – related RNA signal) does not vary with the genotype and
which therefore can serve as internal control for the amount of RNA loaded on the gel. The
RNA – band migrating above the 28S rRNA corresponds to the APE1-mRNA. APE1-
mRNA in via3– mutants (3IVC and 3IVD) is significant lower then those in wild type (C6C)
as well as in via3 – positive spores (3IVA and 3IVB). Smaller RNA species whose signal
intensities are also decreased in via3 are probably degradation products of APE1-mRNA.
1.0 kb
0.7 kb
C6C       3 IVA      3 IV B       3 IV C
Figure 20: Fluorescent image of RNA gel
On the figure is indicated the 28S rRNA (equivalent to 1kb DNA) and the 18S rRNA
(equivalent to 0.7 kb DNA).
C 6 C 3  I V  A 3  I V  B 3  I V  C 3  I V  D
H M W  R N A
A P E 1 - m R N A
1 . 0 k b
0 . 7 k b
Figure 21: Northern blot analysis of via 3 spores
Equal amount of RNA (10µg) was applied per lane (see figure 20). APE1- probe
(1.8 kb) was isolated from p313/LAPIV plasmid with XhoI endonuclease and gel
extraction by Qiagen. The labelling reaction was performed with 32P-dCTP. 2µCi
labelled probe (4.4x106 cpm) in 3 ml hybridisation solution was used for blot
hybridisation. Any decrease in mRNA levels in via3 mutants versus wild type cells
should reflect changes specific to mutation of gene transcription. HMW is a non-
related RNA signal of high molecular weight.
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This result demonstrates that transcription of APE1 is reduced in via3 or that factors
stabilising APE1-mRNA are mutated in via3. However by hybridisation with non-related
genes, as actin or glyceraldehyde 3-phosphate dehydrogenase, has to be performed to verify
the result.
4.4. Analysis of via10 and via14 mutants
As was concluded in chapter 4.3.2., two classes of pApe1p transport mutants have
been identified, via10 and via14, and they were further analysed.
4.4.1. Viability under nutrient starvation
Mutants of autophagy and of the Cvt pathway for pApe1p transport show reduced
viability under nitrogen starvation. In stationary cultures of any media vacuolar protein
degradation is induced. Specific activities of vacuolar enzymes and the transport of proteins to
be degraded to the vacuole are increased. If vacuolar function is impaired cells are unable to
respond to the starvation stress and have a reduced viability. To investigate whether via-
mutants have a similar phenotype, growth curves were recorded.
The growth of via10 and via14 cells was monitored in rich (YPD) and in nitrogen limited
media (MV) and the results are shown on figure 22. Both mutants grew as fast as the wt strain
and reached the same cell densities in rich media, but the via14 mutant showed a prolonged
lag-phase after inoculating the media from a stationary culture (24 h) in rich media (YPD).
Under nitrogen limiting conditions (MV-His) neither of the via-mutants reached the cell
densities of the wt strain. via10 cells grew in the early log-phase as fast as the wt strain. via14
cells displayed a prolonged lag – phase also under these conditions, grew slower then the wt
and did not reach the cell density of the via10 mutant. Differences in cell numbers however are
small, so the number of dead cells in the cultures were measured by tryphan-blue staining.
Both mutant cultures contained 20% dead cells as compared to 6% in the wt culture during
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mid-log phase at glucose concentrations between 1.5-0.5% and up to 40% compared to 15%
in stationary cultures at 0.25% glucose as measured by trypan-blue staining (table 20).
Figure 22: Growth of wt, via10 and via14 cells in rich medium (YPD) and in  nitrogen
limited medium (MV) at 30°C
                 Liquid cultures were inoculated 1:10000 from stationary 24 h YPD cultures.
Table 20: Viability of via-mutants and wild-type
Glucose concentration (%)
in MV
wt via10 via14
1-2 n.d. (start) 14% (start) 14% (start)
0.5 7% (30h) 21% (50h) 21% (77h)
>0.25 15% (50h) 32% (78h) 38% (98h)
Numbers give the amount of dead cells in percent. The culture time is given in parenthesis.
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4.4.2. Vesicular accumulation of pApe1p
The transport of pApe1p to the vacuole can be subdivided into 5 distinct steps:
(1) pApe1p dodecamerization in the cytoplasm,
(2) formation of the cvt vesicle,
(3) transport of the cvt vesicle to the vacuole,
(4) fusion of the cvt vesicle membrane with the vacuolar membrane,
(5) vacuolar degradation of the cvt vesicle inner membrane and proteolytic
 maturation of pApe1p.
To analyze whether in via10 and via14 pApe1p accumulates in the cytosol or in a
membrane enclosed compartment protease protection experiments were performed. The
vesicular localization of pApe1p in via-mutants was analyzed (figure 23) by testing the
susceptibility of the precursor protein to trypsin or proteinase K in the presence or absence of
detergent. Cells in logarithmic growth stage were converted to spheroblasts and lysed with
DEAE-Dextran. Lysis of the spheroblasts and presence of intact vesicles after the lysis were
tested by centrifugation of the lysate at 5000 g and western-blot
pApe1
mApe1
pApe1
mApe1
pApe1
mApe1
CPY          HK         Ape1p
A              B
wt
via10
via14
Figure 23: Subfractionation of pApe1p and mApe1p by 5000 g centrifugation  (A)
    Protease protection assay (B)
    Incubations for protease protection were performed in the absence (-) or presence of
    Triton X-100 as detergent (Det.) and in the absence (-) or presence of trypsin (Tryp)
    or proteinase K (Pr.K). Equivalent of 10 OD600 cells were loaded on each lane
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analysis of pellet and supernatant fractions for the vacuolar carboxypeptidase Y (CPY)
and cytosolic a-hexokinase (aHK).  mApe1p and the majority of pApe1p were found in the
pellet fractions in the wild type (C6C), which is in agreement with previous results (Scott at
al., 1997). The same distribution of Ape1p proteins was found in the via10 mutant. However
in via14 pApe1p was found in the supernatant.
The lysate were incubated for 30 min at 4 °C without proteinase added, with added
trypsin or proteinase K and with or without Triton X-100. In the absence of detergent the
majority of pApe1p was found to be protease protected in via10 and via14 cells as in wild
type cells. Difference concerning protease sensitivity of pApe1p was observed between the
wild type (wt) and the via-mutants when the experiment was performed in the presence of
detergent and using trypsin instead of proteinase K.  Membrane protected pApe1p from wt
cells was resistant to proteolysis by trypsin, but was degraded by proteinase K (figure 23).
pApe1p accumulating in via10 and via14 cells was processed by trypsin to proteins of the
size of the intermediate and mature Ape1p forms. Proteolysis of pApe1p in both via mutants
by proteinase K led to complete degradation of pApe1p. From this result it was concluded
that pApe1p accumulates in a membrane-enclosed compartment in via10 and via14, and that
pApe1p is not in a native conformation in both via mutants.
Prevacuolar accumulation of pApe1p
Figure 24: pApe1p localisation in via14 cells after fractionation of cell lysate   
    Fractionation was performed by centrifugation at 5000 x g and 100000 x g on a 10% ficoll
    cushion.  Equivalent of 10 OD600 cells were loaded on each lane. The symbols on the figure
    represent: the pellet fraction (P), the ficoll fraction (F) and the supernatant fraction (S).
    Fractionation of the vacuolar CPY served as control.
pApe1p
mApe1p
CPY
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In the via14 mutant pApe1p accumulates in pre-vacuolar vesicles, which had a 
lower density then wild type cvt vesicles and were found in a 5000 g supernatant 
fraction in 1.2 M sorbitol. via 14 vesicles were subjected to a 100000 g centrifugation 
(45 min, at 4 °C) onto a 10% ficoll cushion to exclude the possibility that only 
conformational changes of the protein are responsible for the detergent requirement for 
proteolytic degradation. 80% of pApe1p was found at the 10% ficoll fraction, 20% were 
in the supernatant and no pApe1p was found in the pellet (figure 24). 50% of pApe1p in 
the ficoll fraction was protease protected while those in the supernatant were not 
protected. 
 
 C6C 
 
 
 
 
 
via10 
pApe1p
mApe1p
CPY
CE
HK
    0 
  %
0-19
%
   19-25
  %
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    %
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Figure 25: Flotation gradient of wild type (C6C) and via 10   
On the figure are shown the fractions of the Optiprep gradient and the protein crude      
extract (CE ) in homogenate aplied on the gradient. The equivalent of  250 OD600   
cells in logarithmic growth were converted to spheroblasts with zymolyase 20T (cf  
0.5 mg/50OD). Lysed spheroblasts were mixed  with spheroblasts with zymolyase    
20T (cf 0.5 mg/50OD). Lysed spheroblasts were mixed  with Optiprep medium to a  
final concentration of  37% and applied on the bottom of a multi-step gradient (con- 
centration as indicated).  Separation was monitored by western 25000 rpm in a SW- 
40 rotor. 
pApe1p
mApe1p
CPY
0 
%
    0-19
  %
  19-25
 %
  25-30
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In via10 pApe1p accumulated in a membrane enclosed compartment, which co-
fractionated with vacuoles in the protease protection experiment. To test whether 
pApe1p accumulates within vacuoles or in a prevacuolar compartment via10 speroblasts 
(lysed with ) were subjected to flotation gradients in Optiprep. No pellet was formed 
during the centrifugation; lysed spheroblasts remained in the high density fraction.  The 
distribution of precursor and mature pApe1p were analysed by western blot. As intern 
control, the western blot was developed with vacuolar carboxypeptidase Y (CPY) and 
cytosolic α-hexokinase (α HK). In extracts from wild type (C6C) vacuoles and mApe1p 
was found at the 0-19% interface, while cvt vesicles pApe1p were in the 30-37% 
interface. The uncompleted lysis of the spheroblasts, which remained in the high density 
fraction explain the amount of mApe1p and CPY in fraction 30-37% (figure 25). In 
via10 pApe1p was found mainly in 30-37% density fraction and the vacuoles, as in C6C 
at the 0-19% interface. This result shows that pApe1p accumulates in via10 in a pre-
vacuolar compartment. 
 
4.4.2. via 10 and via 14 mutants are deficient in dodecamer formation of pApe1p 
 
As shown by Kim et al. (1997), the pApe1p monomer assembles into a 
homododecameric complex in the cytosol. The dodecameric complex of mApe1p is 
required for its enzymatic activity (Metz and Marx, 1977). The protease protection 
experiments demonstrated an alterated conformation of the pApe1p in the via-mutants. 
Therefore oligomerization of Ape1p was analysed in the via mutants by glycerol density 
centrifugation. 
Crude protein extracts were prepared from cells grown in YPD to OD600 = 0.8-
1.2 by breaking spheroblasts with glass beads in the presence of  protease inhibitors. 10 
fractions of the glycerol gradient were collected and proteins were separated by 10% 
SDS-PAGE. Ape1p was detected by western blot analysis and signal intensities were 
quantified (wincam software). Ovalbumin (45 kDa), bovine serum albumin (65 kDa) 
and thyroglobulin (669k Da) were used to follow separation on the gradient. 
Distribution of mApe1p and pApe1p over the gradient were quantified separately to 
demonstrate the alterations in the distribution of the two proteins. In wt cells 90% of  
Ape1p accumulated  
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pApe1p
mApe1p
pApe1p
mApe1p
pApe1p
mApe1p
Figure 26: pApe1p and mApe1p oligomers separated on a glycerol gradient
On the graphics mApe1p/pApe1p distribution [%] of the fraction number; pApe1p
was represented by (º) and mApe1p by (·). The multiple-step glycerol gradient (2.5
ml) was set up by loading 525 µl of each glycerol  solutions (50, 40, 30 and 20%) and
protein extract (1.5 mg ). 10 fraction (each of  250µl) were collected after
centrifugation for 4 h at 55000 rpm in a TLS-55
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ultracentrifuge rotor and subjected to western blot analysis with antibody against
Ape1p.
as dodecamers of pApe1p and mApe1p in fractions 5, 6 and 7 and 10% of each, pApe1p
as well as  mApe1p, were found in larger complexes in fraction 10 of the gradient
(figure 26-A). In via10 about 10% of total pApe1p are found in fractions 3 and 4 and 20
% of pApe1p are found in fraction 10 demonstrating defects in pApe1p - complex
assembly and formation of high molecular weight aggregates (figure 26-B). In via14
mutant (figure 26-C) 90% of the vacuolar mApe1p form stable dodecameric complexes
as in via10 and wt. pApe1p accumulats in a non-native state in via14 and is almost
evenly distributed over the entire gradient. Slight enrichment was observed in fractions
2 and 9, 10 of the gradient.
4.4.4.  Overexpression of Ssa 1 and Ssa 2 in  via10 and via14 mutants
Heat shock proteins have been shown to assist protein translocation across
membranes, protein folding and protein complex assembly. It has been shown by C.
Satyanarayana (unpublished) that the hsp70 - heat shock proteins Ssa1 and Ssa2 are
involved in the transport of pApe1p from the  cytoplasm into the vacuole. Therefore we
tested whether the defects in the via10 and via14 – mutants can be corrected by Ssa1p
and Ssa2p. Both strains were transformed with each of the genes on a single copy
plasmid containing the gene under its own promotor. Transformants were selected on
MV-HIS, LEU plates and screened by Ape1p-‘overlay’ assay for the complementation
of the Ape1p activity defect. No effect was observed.   Western blot analysis of the
transformants were performed with antibodies against Ape1p and Ssa1/2. In via10
transformed with SSA1 or SSA2 and in via14 transformed with SSA2 pApe1p
processing was upregulated by overexpression of  Ssa1 and Ssa2 (figure 27). No effect
was found in via14 transformed with SSA1.
Whether Ssa 1 or Ssa 2 may assist in oligomerization of pApe1p, protein
extracts were analysed by glycerol gradient experiments. Preliminary data (figure 28)
have not shown any effect on dodecamerization in via10 transformed with Ssa1 or Ssa2
(panel A, B) and also not in via14 transformed with Ssa1 (panel C). Smaller pApe1p
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complexes were still found in the gradient (fractions 2 - 4, hardly seen on figure 28) and
also larger aggregates at the bottom fraction of the gradientare still formed (clearly seen
on fractions 8-10, figure 28). No clear data about Ssa2 involvement in transport of
pApe1p in via14 transformed with Ssa2 were obtained. Further experiments are
required.
A
B
C
Figure 27: Western blot analysis of via-mutants transformed with SSA1 and SSA2
via10 tr. Ssa1, via10 tr. Ssa2, via14 tr. Ssa1 and via14 tr. Ssa2 were named the via
mutants in which Ssa1/2 have been expressed and analized.  In log-phase (FL) and
stationary phase (FS) Ssa1 and Ssa2 induce Ape1p maturation in via10 (panel A). In
via14 only Ssa2 assist pApe1p maturation (C). The weak signal for  Ssa1/2 in via14
is probably due to weak fluorescence signal and an artefact of western blot
development (panel B, via14).
FL             FS FL             FS FL             FS FL             FS
via10
tr Ssa1
via10
tr Ssa2 via10
C6C
Ssa  1/2
pApe1p
mApe1p
FL          FS FL          FS FL          FS
via14
tr SSA 2 via14 C6C
Ssa1/2
pApe1p
mApe1p
via14
tr. Ssa 1
via14
tr. Ssa 2
via14
FL           FS FL            FS FL             FS
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1        2        3        4       5         6         7         8         9         10
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B
C
pApe1p
mApe1p
pApe1p
mApe1p
pApe1p
mApe1p
Figure 28:  Glycerol gradients of via – transformants with Ssa1 or Ssa2
     panel A: via10 tranformed with SSA1; panel B: via10 tranformed with SSA2; panel
     C: via14 tranformed with SSA1; pApe1p agregates at the bottom of the gradient in
     panel A, B, C. The work was performed as described to figure 26.
4.4.5. Library screen for VIA10 and VIA 14 genes
Library screen for VIA10 genes
A genomic DNA library of  S. cerevisiae (fractions named P1- P5, from 13 in
total) on the centromeric plasmid pCS19 was transformed in via10. From 4800 colonies
tested by APE1-overlay assay 22 colonies with increased activity were identified. The
library plasmids were isolated from five of transformants and expressed in E.coli. So
far, two different library plasmids were identified. They were named CA2 and CA4. To
prove the correction of the defect in the positive clones identified by library screening
of via10, via10 was re-transformed with CA2 and CA4. Transformants showed
restoration to 60-70% of wild type Ape1p activity. Therefore, these genes are
suppressors of via10.
 The 2.8 kb/Pst1 fragment and 5.5 kb/Pst I fragment of the CA2 library plasmid
(P11.10) and the 10 kb/Pst1 fragment of CA4 library plasmid (P10.5) were subcloned
into pBluescript II SK vector. The 2.8 kb/Pst1 fragment was found to share 99%
identity to S. cerevisiae chromosome IV – cosmid 8119. They will be further
characterised by subcloning and sequencing.
4. RESULTS
_____________________________________________________________________________________
100
Library screen for VIA14 genes
via14 (14IIA) was transformed with two yeast genomic plasmid libraries
(YCP126 and pYEP13) and transformants were selected on MV-HIS, Leu plates. The
transformants were then screened by Ape1p-‘overlay’ assay. In the case of transforming
14 II A with YCP 126 library, 164 colonies were tested and 3 positive colonies were
identified. In the case of transforming 14IIA with pYEP13 library, from 111 colonies
tested 3 positive colonies were identified. Also these do not restore Ape1p activity to wt
levels and are therefore suppressors of via14 rather then the VIA14 gene. These library
plasmids will be further analysed.
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5. DISCUSSION
A resident vacuolar protein, aminopeptidase 1 (Ape1p) is transported to the
vacuole by a pathway independent of the secretory pathway. It has a long processing
time (45 min) and it‘s maturation involves vacuolar protaeses. Sorting of pApe1p to the
vacuole is mediated by its bipartite N-terminal extension. The active form of Ape1p is a
homododecamer of 600 kDa.
A translocation event at the vesicular / vacuolar membrane or an incorporation
into a cytoplasmic vesicle (as in macroautophagy) or a specific uptake at the vacuolar
membrane (as in microautophagy) were suggested as possible mechanisms of pApe1p
import into the vacuole.
The screen employed by D.J.Klionsky was designed to identify mutants in
pApe1p transport (cvt mutants) by western – blot detection of mutant colonies
accumulating the pApe1p precursor peptide. The autophagy mutants (aut-, apg-) were
selected for defect in the accumulation of autophagy bodies by a screen based on
observations by light microscopy of the EMS mutagenized cells (Thumm, 1994;
Tsukada and Ohsumi, 1993).
Biochemical and morphological studies using cvt-, aut- and apg- mutants
showed that pApe1p is transported to the vacuole directly from the cytoplasm via a
vesicle mediated mechanism termed the cytoplasm to vacuole targeting (Cvt) pathway.
It was suggested that the precursor form of aminopeptidase 1 (pApe1p) rapidly
dodecamerizes in the cytosol and is then enwrapped by a double membrane. The formed
vesicles are transported to and fuse with the vacuolar membrane like an autophagosome
and pApe1p can be detected in single – membrane vesicles within the vacuole of
mutants defective in the degradation of these membranes. During vegetative growth,
pApe1p utilises the Cvt pathway, while under starvation conditions pApe1p is
transported by macroautophagy.
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5.1. A new genetic screen to analyse vacuolar import and autophagocytosis
mutants of aminopeptidase 1
 Our screen was designed to detect mutants in pApe1p transport but based on the
enzymatic activity of the processed and dodecameric Ape1p thus extending the screen
to the end of the trafficking pathway to the vacuole. With this new screen we isolated
mutants which display defects in pApe1p transport which have not been reported for
other mutants isolated so far. They were named via-mutants from vacuolar import and
autophagocytosis. Enzymatic activity of mature and dodecameric mApe1p were assayed
by a culture – plate ‚overlay‘ activity assay. Confirmation of lack of Ape1p - activity in
via mutants was verified by measuring the specific enzymatic activity. This revealed
that via mutants have reduced activities, but that they are higher than expected from the
colony ‘overlay’ – activity assay. The major difference between the two assay-
procedures is that for specific activity measurements Zn2+ is included, which is required
for full enzymatic activity, and that the Leu-pNA is a more specific substrate for Ape1p,
then the Leu-bNA used in the overlay assay.
pApe1p is processed by the endopeptidases PrA and PrB, which reach the
vacuole along the secretory pathway. To test for intact pApe1p processing conditions in
the via-mutants, specific activity of the vacuolar CPY was determined (see 4.2.1.). CPY
reaches the vacuole also by secretory pathway and is also processed by proteases PrA
and PrB. This and the staining of the vacuole with a fluorescent dye revealed an intact
vacuole in via10 and via14 mutants (see 4.3.3. and figure 18).
Two complementation groups were formed so far: via10 and via14. (see 4.3.2.)
Both via–mutants accumulate pApe1p, in membrane enclosed compartments
demonstrating defects in pApe1p transport. While this compartment in via10 was
indistinguishable from the wild type vesicles, the via14 vesicle displayed reduced
density compared to those in wild type cells and are extremely fragile, demonstrating a
severe defect in Cvt vesicle biogenesis.
While in wild type cells all pApe1p and mApe1p are in dodecameric complexes,
assembly of pApe1 into dodecameric complexes is disturbed in both via-mutants.
Besides the formation of aggregates with molecular size higher than the dodecameric
770 kDa in both mutants, smaller complexes of pApe1p were found in both mutants and
are more abundant in via14. The mature Ape1p in the mutants instead was found to be
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dodecameric, which is in agreement with the specyfic enzymatic activities found in the
mutants. However the increased sensitivity of the pApe1p to denaturation conditions
indicates that the dodecamer is not properly assembled or stabilized.
In the model for the Cvt pathway (Scott and Klionsky, 1996) pApe1p rapidly
dodecamerizes in the cytoplasm and is then enwrapped by a double membrane. These
vesicles are transported to and fuse with the vacuolar membrane like an autophagosome
and pApe1p can be detected in single – membrane vesicles in the vacuole in mutants
defective in the degradation of these membranes. In the via- mutants, formation of the
surrounding membrane takes place, but pApe1p is not properly assembled; smaller
complexes and also aggregates are formed. This phenotype was not previously
described in the cvt and apg, aug mutants analysed so far (figure 29).
Processing of pApe1p in the via-mutants by trypsin in the presence of detergent
leads to the formation of intermediate sized proteins of the same molecular mass as the
intermediate and mature forms of the protein generated by the vacuolar endopeptidases
proteinase A and proteinase B in vivo. The same experiment performed in the absence
of detergent did not lead to the pApe1p processing. This indicates that the signal
sequence is protease protected. The increased sensitivity to proteases and the defect in
dodecamerisation in the via cells indicates that Cvt vesicles in wild type cells contain
factors which stabilize the dodecamer.
5.2. Model of pApe1p transport based on via10 and via14 phenotype
In the model for the Cvt pathway, pApe1p rapidly dodecamerizes in the
cytoplasm with a T1/2 = 2 min. The dodecamer is then enwrapped by a double-
membrane to form the electron dense cvt vesicle. Formation of the Cvt vesicle and ist
vacuolar transport requires additional 43 min (figure 29 - a). This is extremely slow
compared to the T1/2 = 5 min for the CPY transport through the secretory pathway. The
via-mutants reveal that Cvt vesicle formation and pApe1p dodecamerization are linked
processes.
We do not know whether in via-mutants smaller pApe1p complexes are
enwrapped by a membrane or whether dodecamers initially form in the cytoplasm,
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become enwrapped, but are less stable in the vesicles (Figure 29: b). Klionsky reported
that Cvt vesicles are small and contain a dense core of pApe1p dodecamers which
a
b
c
Figure 29: Model of pApe1p transport based on via10 and via 14 phenotype
     a: Cvt pathway;
     b: mutant phenotype in via10 and via14
     c: modification of the model for the Cvt pathway based on via10 and via14
         phenotypes
would not leave space for dissociation and re-association reactions. via10 vesicles have
the same density as wt vesicles, but pApe1 dodecamerisation is affected. Furthermore,
we observe in both mutants enhanced formation of large pApe1p aggregates, indicating
an uncoordinated complex formation and not absence of complex formation. In addition
vacuolar dodecameric mApe1p displays increased sensitivity to denaturing conditions
(see 4.4.2), demonstrating that these complexes are not in a native state. This can also
explain the reduced amount of mApe1p in the mutants. The proper oligomerisation is
disturbed in both via mutants. The accumulation of pApe1p in prevacuolar vesicles
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demonstrates that complex formation as well as vesicular transport are disturbed,
indicating that formation of transport vesicles and oligomerisation are linked processes
(figure 29: c). This could be caused for example by chaperones normally present in
those vesicles, which interact with pApe1p as well as proteins required for vacuolar
transport of Cvt vesicles. This interpretation is supported by the observation that Ssa1/2
can stimulate vacuolar transport, but this does not restore Ape1p enzymatic activity (see
4.4.4.).
5.3. Specificity of via-mutants
Ape1p was shown to use two pathways for vacuolar import: constitutively, the
cytoplasm to vacuole pathway, and the, predicted as being non-selective, autophagy
pathway when high protein turnover is necessary for the cell to adapt to a new state.
Majority of mutants in the autophagy and Cvt pathways display the same phenotypes on
pApe1p transport (Harding et al., Scott et al., 1996). Inhibition of peroxisome
degradation in cvt and apg mutants indicates that these pathways also overlap with that
of peroxisomal degradation pathway (selective autophagocytosis or microautophagy) to
the vacuole (Hutchins et al., 1999). To test the specificity of the defect in pApe1p
transport in via mutants studies are in progress for the analysis of pexophagy. I followed
in via mutants the aPcs60p induced expression by starvation in rich and selective
medium (YPD, MV) as well as in medium containing oleic acid (YPO) and its
degradation upon shift into fresh rich and selective medium (YPD, MV). Preliminary
results suggest that pexophagy is not affected in via10. This supports the view that this
new genetic screen is usefull to isolate mutants with specific defects in pApe1p
transport.
At the moment , the identification of the VIA10 and VIA14 genes by a library
cloning approach is under the way. However, since many mutants are generated and the
complete yeast genome sequences are available, an approach based on proteom analysis
(Patterson and Aebersold, 1995; Shevchenko et al, 1996) might hurry the identification
of VIA10 and VIA14 gene products. This approach would have the advantage of
shortening the way of identifying the proteins involved in pApe1p transport. Implication
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of an identified protein has to be verified by generating a knock-out of the encoding
gene.
6. CONCLUDING REMARKS
__________________________________________________________________________________________________________
107
6. CONCLUDING REMARKS
A new genetic screen for pApe1p transport mutants was performed to isolate
new transport mutants.
Characterization of the transport defects in two via mutants reveals that pApe1p
dodecamer formation and Cvt vesicle formation are linked processes. This is a new and
unexpected finding, because rapid formation of the stable pApe1p dodecamer was
observed in the cytosol of wt cells and Cvt vesicles contain dense core pApe1p
complexes.
The strategy to use the enzymatic activity of dodecameric mApe1p to search for
new pApe1p transport mutants has turned out to be useful for the isolation of specific
pApe1p transport mutants.
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